https://biolegacyresearch.com/besightb-3-launches-in-europe/ 2017-06-23T00:00:00+00:00 https://biolegacyresearch.com/survey-says-here-are-the-4-most-liked-life-science-ceos/ 2017-06-23T00:00:00+00:00 https://biolegacyresearch.com/clasado-to-exhibit-at-in-las-vegas/ 2017-06-23T00:00:00+00:00 https://biolegacyresearch.com/strongbridge-biopharma-announces-new-employment-inducement-awards/ 2017-06-23T00:00:00+00:00 https://biolegacyresearch.com/bluebird-bio-touts-impressive-data-from-late-stage-gene-therapy-study/ 2017-06-23T00:00:00+00:00 https://biolegacyresearch.com/leo-pharma-appoints-to-lead-us-business/ 2017-06-23T00:00:00+00:00 https://biolegacyresearch.com/hospiras-epoetin-biosimilar-delayed-following-crl-over-gmp-violations/ 2017-06-23T20:17:58+00:00 https://biolegacyresearch.com/congressional-diabetes-caucus-calls-for-meeting-with-industry-groups-on-insulin-price-hikes/ 2017-06-23T20:19:06+00:00 https://biolegacyresearch.com/jury-awards-gsk-235-million-after-teva-added-heart-failure-indication-to-generic-coreg/ 2017-06-23T20:20:20+00:00 https://biolegacyresearch.com/otc-sleep-drug-named-after-antidepressant-is-misbranded-and-misleading-warns-fda/ 2017-06-23T20:21:13+00:00 https://biolegacyresearch.com/emas-chmp-issues-eight-positive-opinions-including-two-hep-c-antiviral-combinations/ 2017-06-23T20:23:36+00:00 https://biolegacyresearch.com/hebron-technology-co-signs-framework-agreement-to-form-jv-with-ukrainian-company/ 2017-06-26T00:00:00+00:00 https://biolegacyresearch.com/these-are-the-top-5-biotech-stocks-so-far/ 2017-06-26T00:00:00+00:00 https://biolegacyresearch.com/tracelink-inc-announces-end-to-end-administration-for-product-track-alleviating-time-intensive-dscsa-compliance-tasks-for-u-s-hospitals-and-pharmacies/ 2017-06-26T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-portola-rockets-as-the-fda-approves-first-and-only-anticoagulant-for-hospitals/ 2017-06-26T00:00:00+00:00 https://biolegacyresearch.com/novo-nordisk-as-share-repurchase-programme/ 2017-06-26T00:00:00+00:00 https://biolegacyresearch.com/2-biotech-stocks-that-exploded-500-in-the-last-3-years/ 2017-06-26T00:00:00+00:00 https://biolegacyresearch.com/bares-genetics-gmbhb-release-company-news-gear-predicting-antibiotic-resistances-with-genetic-data-succeeds-in-competition-landmarks-in-the-land-of-ideas/ 2017-06-26T00:00:00+00:00 https://biolegacyresearch.com/massachusetts-selecta-banks-50-million/ 2017-06-26T00:00:00+00:00 https://biolegacyresearch.com/bprovention-biob-secures-28-4-million-founding-financing-to-fund-development-targeting-the-interception-and-prevention-of-immune-mediated-disease/ 2017-06-26T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-kindred-bio-scoops-up-boehringer-ingelheims-former-space-in-kansas/ 2017-06-26T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-previews-plans-for-generics-competition-innovative-tech-approvals/ 2017-06-26T21:32:21+00:00 https://biolegacyresearch.com/pharma-could-get-policy-boost-from-executive-order/ 2017-06-26T21:33:10+00:00 https://biolegacyresearch.com/indiana-compounder-indicted-on-conspiracy-drug-potency/ 2017-06-26T21:34:14+00:00 https://biolegacyresearch.com/nonprofit-sues-celgene-for-blocking-generic-competition/ 2017-06-26T21:35:19+00:00 https://biolegacyresearch.com/ema-publishes-checklist-ahead-of-november-eudravigilance-update/ 2017-06-26T21:36:17+00:00 https://biolegacyresearch.com/analytics-firm-pulls-back-on-drug-revenue-projections/ 2017-06-26T21:37:18+00:00 https://biolegacyresearch.com/cerulean-urges-stockholders-to-vote-for-proposals-at-july-19-2017-special-stockholder-meeting/ 2017-06-27T00:00:00+00:00 https://biolegacyresearch.com/fda-approval-of-drug-may-have-made-this-bay-area-pharma-a-new-ma-target/ 2017-06-27T00:00:00+00:00 https://biolegacyresearch.com/cellectis-reports-results-from-annual-general-meeting-held-on-june-26-2017/ 2017-06-27T00:00:00+00:00 https://biolegacyresearch.com/what-makes-biogen-and-bristol-myers-squibb-such-attractive-takeover-targets/ 2017-06-27T00:00:00+00:00 https://biolegacyresearch.com/jacobson-pharma-announces-2017-annual-results/ 2017-06-27T00:00:00+00:00 https://biolegacyresearch.com/merck-co-s-midas-touch-continues-as-heart-drug-succeeds-where-pfizer-eli-lilly-and-roches-failed/ 2017-06-27T00:00:00+00:00 https://biolegacyresearch.com/invivo-therapeutics-announces-new-patient-enrollment-into-the-inspire-study-at/ 2017-06-27T00:00:00+00:00 https://biolegacyresearch.com/a-look-at-the-deaths-that-plagued-juno-and-kite-pharmas-car-t-trials/ 2017-06-27T00:00:00+00:00 https://biolegacyresearch.com/lattice-biologics-ltd-announces-move-to-belgrade-montana/ 2017-06-27T00:00:00+00:00 https://biolegacyresearch.com/pharma-bro-manages-to-elect-five-pals-to-turings-board-before-trial/ 2017-06-27T00:00:00+00:00 https://biolegacyresearch.com/fda-publishes-list-of-generic-ready-ndas-as-action-plan-to-boost-competition-takes-shape/ 2017-06-27T21:49:00+00:00 https://biolegacyresearch.com/gao-generics-getting-faster-approvals-but-fda-needs-plan-to-use-extra-gdufa-funds/ 2017-06-27T21:50:29+00:00 https://biolegacyresearch.com/texas-expands-right-to-try-laws-to-include-investigational-stem-cell-treatments/ 2017-06-27T21:51:33+00:00 https://biolegacyresearch.com/millennium-petitions-fda-to-hold-off-on-approvals-of-generic-velcade/ 2017-06-27T21:52:44+00:00 https://biolegacyresearch.com/fda-warns-new-jersey-drugmaker-over-gmp-violations/ 2017-06-27T21:53:44+00:00 https://biolegacyresearch.com/adicet-bio-appoints-chief-medical-officer/ 2017-06-28T00:00:00+00:00 https://biolegacyresearch.com/pfizer-expects-to-hire-80-new-staffers-after-completion-of-200-million-rd-facility/ 2017-06-28T00:00:00+00:00 https://biolegacyresearch.com/insulet-mayo-clinic-jump-in-on-35-million-series-c-funding-round/ 2017-06-28T00:00:00+00:00 https://biolegacyresearch.com/two-former-ariad-directors-charged-with-insider-trading/ 2017-06-28T00:00:00+00:00 https://biolegacyresearch.com/bristol-myers-squibb-release-modern-family-star-eric-stonestreet-challenges-americans-to-support-the-cancer-community-and-learn-about-immuno-oncology-research-through-ready-raise-rise/ 2017-06-28T00:00:00+00:00 https://biolegacyresearch.com/after-fda-rejection-bay-areas-coherus-axes-30-of-employees/ 2017-06-28T00:00:00+00:00 https://biolegacyresearch.com/k2m-first-to-market-with-3d-printed-corpectomy-cage-system-following-fda-clearance-of-capri-small-3d-static-featuring-lamellar-3d-titanium-technology/ 2017-06-28T00:00:00+00:00 https://biolegacyresearch.com/gop-congressman-lost-16-7-million-in-single-day-on-this-tanking-biotech-stock/ 2017-06-28T00:00:00+00:00 https://biolegacyresearch.com/bbmi-systemb-release-appointment-of-bjerome-martinezb-as-president/ 2017-06-28T00:00:00+00:00 https://biolegacyresearch.com/merck-co-becomes-victim-of-massive-ransomware-cyber-attack/ 2017-06-28T00:00:00+00:00 https://biolegacyresearch.com/fda-funding-bill-advances-in-the-house/ 2017-06-28T21:24:07+00:00 https://biolegacyresearch.com/fda-taking-comments-on-bsufa-ii-review-assessment-project/ 2017-06-28T21:24:53+00:00 https://biolegacyresearch.com/fda-relaxes-14-year-old-recommendations-for-medical-gas-gmp-compliance/ 2017-06-28T21:26:42+00:00 https://biolegacyresearch.com/va-will-use-icer-drug-assessment-reports-in-industry-price-negotiations/ 2017-06-28T21:27:36+00:00 https://biolegacyresearch.com/sterrx-cited-for-sterility-issues/ 2017-06-28T21:28:31+00:00 https://biolegacyresearch.com/dova-pharma-announces-pricing-of-initial-public-offering/ 2017-06-29T00:00:00+00:00 https://biolegacyresearch.com/roche-to-slash-75-jobs-in-massachusetts-more-consolidation-to-come/ 2017-06-29T00:00:00+00:00 https://biolegacyresearch.com/iteos-therapeutics-appoints-as-vice-president-corporate-development/ 2017-06-29T00:00:00+00:00 https://biolegacyresearch.com/sarepta-taps-allergan-alum-as-new-ceo/ 2017-06-29T00:00:00+00:00 https://biolegacyresearch.com/multiple-myeloma-research-foundation-mmrf-announces-15-million-investment-in-immunotherapy-initiative/ 2017-06-29T00:00:00+00:00 https://biolegacyresearch.com/omeros-pursuing-legal-action-against-short-seller-for-report-that-caused-stock-to-tank-this-week/ 2017-06-29T00:00:00+00:00 https://biolegacyresearch.com/varian-medical-systems-gets-fda-510k-clearance-for-halcyon-treatment-system/ 2017-06-29T00:00:00+00:00 https://biolegacyresearch.com/tigenix-begins-recruiting-for-new-u-s-hq-in-massachusetts/ 2017-06-29T00:00:00+00:00 https://biolegacyresearch.com/akebia-announces-pricing-of-public-offering-of-common-stock/ 2017-06-29T00:00:00+00:00 https://biolegacyresearch.com/biotech-startups-salivate-as-atlas-venture-launches-350-million-fund/ 2017-06-29T00:00:00+00:00 https://biolegacyresearch.com/fda-orphan-products-office-to-focus-on-clearing-backlog/ 2017-06-29T22:04:53+00:00 https://biolegacyresearch.com/european-commission-unveils-new-antimicrobial-resistance-action-plan/ 2017-06-29T22:05:44+00:00 https://biolegacyresearch.com/compounder-warned-for-long-list-of-gmp-violations/ 2017-06-29T22:06:30+00:00 https://biolegacyresearch.com/3-biotechs-with-bulging-pipelines-that-could-also-become-attractive-takeover-targets/ 2017-06-30T00:00:00+00:00 https://biolegacyresearch.com/zoetis-to-host-webcast-and-conference-call-on-second-quarter-2017-financial-results/ 2017-06-30T00:00:00+00:00 https://biolegacyresearch.com/shire-to-consolidate-3000-jobs-over-4-years-to-2-massachusetts-sites/ 2017-06-30T00:00:00+00:00 https://biolegacyresearch.com/tauriga-secures-investment-of-80000-usd-through-a-5-promissory-note-with-fixed-conversion-price-of-0-00125-per-share/ 2017-06-30T00:00:00+00:00 https://biolegacyresearch.com/this-new-jersey-biotech-is-set-to-grow-eps-by-39100-through-2020/ 2017-06-30T00:00:00+00:00 https://biolegacyresearch.com/a-double-keiba-win-for-bedfont-scientific-totals-4-business-awards-this-year/ 2017-06-30T00:00:00+00:00 https://biolegacyresearch.com/the-2-biotechs-that-turned-8000-into-at-least-25600-in-just-one-year/ 2017-06-30T00:00:00+00:00 https://biolegacyresearch.com/adm-tronics-reports-fiscal-year-2017/ 2017-06-30T00:00:00+00:00 https://biolegacyresearch.com/struggling-mannkind-hires-financial-advisor-after-maxing-out-its-last-credit-line/ 2017-06-30T00:00:00+00:00 https://biolegacyresearch.com/medidata-solutions-inc-release-chugai-deploys-ravex-to-modernize-post-marketing-surveillance/ 2017-06-30T00:00:00+00:00 https://biolegacyresearch.com/carsgen-therapeutics-joins-the-alliance-for-regenerative-medicine/ 2017-06-30T00:00:00+00:00 https://biolegacyresearch.com/infusystem-holdings-inc-announces-amendment-to-existing-credit-facility-with/ 2017-06-30T00:00:00+00:00 https://biolegacyresearch.com/manufacturing-safety-concerns-sparks-phillips-recall/ 2017-07-03T17:13:00+00:00 https://biolegacyresearch.com/manufacturing-safety-concerns-sparks-phillips/ 2017-07-03T17:13:08+00:00 https://biolegacyresearch.com/poor-quality-factor-in-stratus-sonar-shut-down-by-federal-judge/ 2017-07-03T17:14:22+00:00 https://biolegacyresearch.com/483-roundup-sterility-cleanliness-common-threads-in-form-483s/ 2017-07-03T17:15:35+00:00 https://biolegacyresearch.com/ipca-products-banned-from-u-s-market-after-drug-shortage-ends/ 2017-07-03T17:16:49+00:00 https://biolegacyresearch.com/warning-letter-roundup-size-doesnt-matter/ 2017-07-03T17:17:57+00:00 https://biolegacyresearch.com/facility-inspections-factor-in-slow-generics-reviews-says-gao/ 2017-07-03T17:19:01+00:00 https://biolegacyresearch.com/indiana-compounders-indicted-on-conspiracy-drug-quality/ 2017-07-03T17:20:25+00:00 https://biolegacyresearch.com/india-releases-draft-sop-for-handling-out-of-specification-drug-samples/ 2017-07-03T17:21:34+00:00 https://biolegacyresearch.com/quality-issues-lead-to-shuttering-of-tevas-hungarian-plant/ 2017-07-03T17:22:57+00:00 https://biolegacyresearch.com/strides-gets-483-for-quality-problems/ 2017-07-03T17:23:59+00:00 https://biolegacyresearch.com/fda-delays-enforcement-of-supply-chain-identifier-requirements-for-one-year/ 2017-07-03T18:02:35+00:00 https://biolegacyresearch.com/supplement-company-warned-on-unapproved-ingredients-gmps/ 2017-07-03T18:03:57+00:00 https://biolegacyresearch.com/fda-and-ema-collaborate-on-expandable-model-for-rare-pediatric-drug-development/ 2017-07-03T19:47:37+00:00 https://biolegacyresearch.com/sandoz-requests-california-court-make-final-decision-in-amgen-biosimilar-case/ 2017-07-03T19:49:14+00:00 https://biolegacyresearch.com/bgdmb-and-benson-hill-biosystems-establish-strategic-collaboration-to-accelerate-soybean-breeding/ 2017-07-05T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-biggest-startup-factory-looks-to-fund-this-new-type-of-biotech/ 2017-07-05T00:00:00+00:00 https://biolegacyresearch.com/celgene-to-announce-second-quarter-2017-results-on-july-27-2017/ 2017-07-05T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-coherus-dealt-another-blow-as-daiichi-sankyo-discontinues-work-on-ra-drug/ 2017-07-05T00:00:00+00:00 https://biolegacyresearch.com/bseventure-partnersb-health-for-life-capital-participates-in-13-2-million-financing-of-japanese-microbiome-leader-banaeropharma-scienceb/ 2017-07-05T00:00:00+00:00 https://biolegacyresearch.com/bristol-myers-squibbs-opdivo-prevails-in-phase-iii-melanoma-trial/ 2017-07-05T00:00:00+00:00 https://biolegacyresearch.com/the-announces-at-and-harvard-medical-school/ 2017-07-05T00:00:00+00:00 https://biolegacyresearch.com/3-key-reasons-why-a-gilead-vertex-marriage-may-not-be-a-match-made-in-biotech-heaven/ 2017-07-05T00:00:00+00:00 https://biolegacyresearch.com/sanbio-inc-receives-20-million-grant-from-for-stroke-clinical-trial/ 2017-07-05T00:00:00+00:00 https://biolegacyresearch.com/why-theranos-could-burn-through-all-its-cash-by-the-end-of-this-year/ 2017-07-05T00:00:00+00:00 https://biolegacyresearch.com/ema-and-eunethta-launch-joint-gateway-for-parallel-advice/ 2017-07-05T22:04:22+00:00 https://biolegacyresearch.com/chinese-heparin-testing-lab-warned-by-fda/ 2017-07-05T22:06:06+00:00 https://biolegacyresearch.com/allergan-settles-kickback-lawsuit-for-13-million/ 2017-07-05T22:07:12+00:00 https://biolegacyresearch.com/industry-group-petitions-fda-to-withdraw-approvals-of-non-abuse-deterrent-opioids/ 2017-07-05T22:08:48+00:00 https://biolegacyresearch.com/cber-expands-its-2017-guidance-agenda/ 2017-07-05T22:09:46+00:00 https://biolegacyresearch.com/oxitecs-friendly-aedes-mosquito-receives-positive-evaluation-for-european-standard-in-relation-to-human-health-and-the-environment/ 2017-07-06T00:00:00+00:00 https://biolegacyresearch.com/patient-deaths-prompt-the-fda-to-suspend-three-of-merck-co-s-keytruda-trials/ 2017-07-06T00:00:00+00:00 https://biolegacyresearch.com/new-data-to-be-presented-at-isth-underscore-bioverativs-commitment-to-advance-hemophilia-care/ 2017-07-06T00:00:00+00:00 https://biolegacyresearch.com/biotech-bestie-celgene-takes-stake-inks-1-billion-deal-with-beigene/ 2017-07-06T00:00:00+00:00 https://biolegacyresearch.com/caribou-biosciences-appoints-ph-d-as-chief-scientific-officer/ 2017-07-06T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-that-could-be-sweet-ma-targets-for-big-pharma/ 2017-07-06T00:00:00+00:00 https://biolegacyresearch.com/university-of-pennsylvania-installs-second-milabs-ultra-high-resolution-preclinical-imaging-system/ 2017-07-06T00:00:00+00:00 https://biolegacyresearch.com/what-does-it-take-to-get-hired-by-glaxosmithkline-and-abbvie/ 2017-07-06T00:00:00+00:00 https://biolegacyresearch.com/inventiva-announces-first-half-2017-financial-and-corporate-update/ 2017-07-06T00:00:00+00:00 https://biolegacyresearch.com/top-9-biotech-giants-to-work-for-in-new-jersey/ 2017-07-06T00:00:00+00:00 https://biolegacyresearch.com/cbo-scores-user-fee-reauthorization-package/ 2017-07-06T20:49:18+00:00 https://biolegacyresearch.com/ptab-nixes-two-more-humira-dosing-patents-following-coherus-challenges/ 2017-07-06T20:49:43+00:00 https://biolegacyresearch.com/who-essential-medicines-list-adds-drugs-for-hep-c-hiv-new-antibiotics/ 2017-07-06T20:52:43+00:00 https://biolegacyresearch.com/jury-awards-gsk-235m-after-teva-adds-chf-indication-to-coreg-label/ 2017-07-06T20:55:36+00:00 https://biolegacyresearch.com/fda-rejects-coherus-neulasta-biosimilar-calls-for-new-analyses/ 2017-07-06T20:55:56+00:00 https://biolegacyresearch.com/aam-patients-nearly-3-times-more-likely-to-not-pick-up-branded-drugs/ 2017-07-06T20:57:36+00:00 https://biolegacyresearch.com/endo-withdraws-opana-painkiller-from-market-at-fdas-request/ 2017-07-06T22:02:13+00:00 https://biolegacyresearch.com/ema-defers-u-s-gmp-inspections-pending-november-activation-of-mutual-agreement/ 2017-07-06T22:04:16+00:00 https://biolegacyresearch.com/klobuchar-calls-on-diabetes-drugmakers-to-justify-price-hikes/ 2017-07-06T22:05:13+00:00 https://biolegacyresearch.com/compounder-ordered-to-halt-operations/ 2017-07-06T22:06:08+00:00 https://biolegacyresearch.com/cmc-biologics-to-hire-100-to-150-employees-in-washington/ 2017-07-07T00:00:00+00:00 https://biolegacyresearch.com/bmapi-research-trustb-appointed-as-exclusive-distributor-and-mapi-language-services-as-exclusive-translator-of-the-disease-activity-score-das-28/ 2017-07-07T00:00:00+00:00 https://biolegacyresearch.com/alexion-is-under-investigation-by-the-office-of-inspector-general/ 2017-07-07T00:00:00+00:00 https://biolegacyresearch.com/bioverativ-to-report-second-quarter-2017-financial-results-on-august-2-2017/ 2017-07-07T00:00:00+00:00 https://biolegacyresearch.com/booming-jazz-pharma-inks-huge-lease-in-philadelphia-to-accomodate-growth/ 2017-07-07T00:00:00+00:00 https://biolegacyresearch.com/spineguard-looks-to-break-even-by-2018-names-co-founder-ceo/ 2017-07-07T00:00:00+00:00 https://biolegacyresearch.com/waiting-lists-are-already-forming-for-novartis-ag-and-kite-pharmas-not-yet-approved-car-t-drugs/ 2017-07-07T00:00:00+00:00 https://biolegacyresearch.com/isoray-announces-appointment-of-as-controller-principal-accounting-and-financial-officer/ 2017-07-07T00:00:00+00:00 https://biolegacyresearch.com/effective-immediately-advaxis-ceo-resigns-interim-leader-named/ 2017-07-07T00:00:00+00:00 https://biolegacyresearch.com/radius-health-to-announce-second-quarter-2017-financial-results-host-conference-call-and-live-webcast-on-august-3-2017/ 2017-07-07T00:00:00+00:00 https://biolegacyresearch.com/fda-to-expand-high-performance-computing-to-boost-clinical-trial-efficiency/ 2017-07-07T21:51:32+00:00 https://biolegacyresearch.com/pacira-shutters-depcyt-operations-after-years-of-manufacturing-problems/ 2017-07-07T21:52:29+00:00 https://biolegacyresearch.com/fda-approves-first-new-sickle-cell-drug-in-20-years/ 2017-07-07T21:53:19+00:00 https://biolegacyresearch.com/ptab-invalidates-abbvies-humira-dosing-patent-again/ 2017-07-07T21:54:09+00:00 https://biolegacyresearch.com/aam-sues-maryland-to-block-generic-drug-price-gouging-law/ 2017-07-07T21:55:04+00:00 https://biolegacyresearch.com/sinovac-hid-cfda-bribes-sec-investigation-from-shareholders-lawsuit-claims/ 2017-07-07T21:55:58+00:00 https://biolegacyresearch.com/immunarray-enters-partnership-with/ 2017-07-10T00:00:00+00:00 https://biolegacyresearch.com/the-3-biotechs-that-could-make-celgene-even-richer/ 2017-07-10T00:00:00+00:00 https://biolegacyresearch.com/biogen-appoints-vice-president-of-government-affairs/ 2017-07-10T00:00:00+00:00 https://biolegacyresearch.com/retired-celgene-alum-lands-chairman-gig-at-biotech-guru/ 2017-07-10T00:00:00+00:00 https://biolegacyresearch.com/bnemaura-medical-inc-b-announces-uplist-to-otcqb/ 2017-07-10T00:00:00+00:00 https://biolegacyresearch.com/production-problems-lead-pacira-to-cut-jobs-in-san-diego/ 2017-07-10T00:00:00+00:00 https://biolegacyresearch.com/providence-medical-technology-announces-publication-of-two-new-studies-supporting-tissue-sparing-posterior-cervical-fusion/ 2017-07-10T00:00:00+00:00 https://biolegacyresearch.com/why-amgen-needs-an-acquisition-to-keep-up-with-immuno-oncology-competitors/ 2017-07-10T00:00:00+00:00 https://biolegacyresearch.com/ag-biotech-company-announces-24mm-c-round-financing/ 2017-07-10T00:00:00+00:00 https://biolegacyresearch.com/massachusetts-inotek-exploring-strategic-alternatives-after-another-glaucoma-trial-failure/ 2017-07-10T00:00:00+00:00 https://biolegacyresearch.com/fda-will-issue-tougher-validation-requirements-for-reusable-devices/ 2017-07-10T20:38:08+00:00 https://biolegacyresearch.com/south-africas-new-device-regs-are-now-live/ 2017-07-10T20:45:15+00:00 https://biolegacyresearch.com/how-to-manage-risk-in-a-world-of-changing-design-control-standards/ 2017-07-10T20:46:28+00:00 https://biolegacyresearch.com/483-roundup-fda-cites-firms-over-complaint-handling-other-deficiencies/ 2017-07-10T20:47:43+00:00 https://biolegacyresearch.com/australian-parliament-passes-new-device-reforms/ 2017-07-10T20:49:35+00:00 https://biolegacyresearch.com/cardiac-devices-pose-cybersecurity-challenges-study-finds/ 2017-07-10T20:50:59+00:00 https://biolegacyresearch.com/malaysia-issues-new-mandatory-device-reporting-requirements/ 2017-07-10T20:51:52+00:00 https://biolegacyresearch.com/fda-to-expand-opioid-rems-to-include-immediate-release-painkillers/ 2017-07-10T22:25:35+00:00 https://biolegacyresearch.com/generic-approvals-continue-to-speed-forward/ 2017-07-10T22:26:45+00:00 https://biolegacyresearch.com/appeals-court-reinstates-fca-whistleblower-lawsuit-against-gilead/ 2017-07-10T22:28:08+00:00 https://biolegacyresearch.com/texas-pharmacy-warned-on-sterility-and-more-gmp-violations/ 2017-07-10T22:29:16+00:00 https://biolegacyresearch.com/neurometrix-announces-7-0-million-private-placement-of-preferred-stock/ 2017-07-11T00:00:00+00:00 https://biolegacyresearch.com/booming-c4-therapeutics-to-move-out-of-pricey-kendall-square-next-year/ 2017-07-11T00:00:00+00:00 https://biolegacyresearch.com/bnda-groupb-expands-service-offerings-and-geographic-reach-appointing-new-us-service-area-leaders-and-head-of-business-development/ 2017-07-11T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-oncomed-tanks-some-more-as-glaxosmithkline-walks-away-from-rd-pact/ 2017-07-11T00:00:00+00:00 https://biolegacyresearch.com/halozyme-to-host-second-quarter-2017-financial-results-conference-call/ 2017-07-11T00:00:00+00:00 https://biolegacyresearch.com/san-diegos-arena-soars-as-phase-ii-hypertension-trial-data-wows/ 2017-07-11T00:00:00+00:00 https://biolegacyresearch.com/histogenics-announces-publication-of-data-from-collagen-and-chondrocyte-3-d-bioprinting-study/ 2017-07-11T00:00:00+00:00 https://biolegacyresearch.com/groundbreaking-amicus-surges-as-the-fda-changes-its-tune-on-fabry-disease-drug/ 2017-07-11T00:00:00+00:00 https://biolegacyresearch.com/bioiq-announces-the-first-unified-solution-for-configuring-and-managing-population-health-testing-programs/ 2017-07-11T00:00:00+00:00 https://biolegacyresearch.com/neothetics-to-slash-an-unknown-number-of-jobs-review-strategic-alternatives/ 2017-07-11T00:00:00+00:00 https://biolegacyresearch.com/fda-ad-comm-recommends-new-mylotarg-dose-for-combination-aml-treatment/ 2017-07-11T22:19:14+00:00 https://biolegacyresearch.com/gao-fda-must-clarify-how-expanded-access-data-will-be-used/ 2017-07-11T22:19:58+00:00 https://biolegacyresearch.com/fda-reverses-course-will-allow-amicus-to-submit-fabry-disease-nda/ 2017-07-11T22:20:53+00:00 https://biolegacyresearch.com/ema-adopts-five-product-specific-bioequivalence-guidances/ 2017-07-11T22:21:46+00:00 https://biolegacyresearch.com/vista-pharmaceuticals-warned-on-facility-disrepair-other-violations/ 2017-07-11T22:22:36+00:00 https://biolegacyresearch.com/kindred-bio-announces-proposed-public-offering-of-common-stock/ 2017-07-12T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-galena-biopharma-slashes-jobs-while-exploring-strategic-alternatives/ 2017-07-12T00:00:00+00:00 https://biolegacyresearch.com/active-implants-appoints-and-to-board/ 2017-07-12T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-e-scape-bio-bursts-out-of-stealth-mode-with-63-million-to-tackle-alzheimers/ 2017-07-12T00:00:00+00:00 https://biolegacyresearch.com/volpara-to-showcase-volpara-enterprise-ddp-software-at/ 2017-07-12T00:00:00+00:00 https://biolegacyresearch.com/biospace-partners-with-to-offer-cost-savings-to-members/ 2017-07-12T00:00:00+00:00 https://biolegacyresearch.com/bsynergy-radiology-associatesb-radiologists-using-hi-tech-3-d-imaging-for-better-prostate-cancer-diagnosis-less-worry/ 2017-07-12T00:00:00+00:00 https://biolegacyresearch.com/two-bay-area-diagnostic-companies-win-amgens-golden-ticket/ 2017-07-12T00:00:00+00:00 https://biolegacyresearch.com/noxxon-pharma-ag-announces-prospectus-publication-and-share-transfer-to-the-public-offering-compartment-of-the-euronext-growth-market/ 2017-07-12T00:00:00+00:00 https://biolegacyresearch.com/5-best-biotech-stocks-to-buy-in-the-2nd-half-of-2017/ 2017-07-12T00:00:00+00:00 https://biolegacyresearch.com/house-committee-approves-bill-including-fda-2018-funding/ 2017-07-12T22:03:40+00:00 https://biolegacyresearch.com/house-passes-fda-user-fee-reauthorization-package/ 2017-07-12T22:05:07+00:00 https://biolegacyresearch.com/states-call-on-lawmakers-for-help-to-fight-opioid-crisis/ 2017-07-12T22:06:07+00:00 https://biolegacyresearch.com/fda-advisory-committee-sees-benefits-of-car-t-leukemia-therapy/ 2017-07-12T22:07:03+00:00 https://biolegacyresearch.com/fresenius-petitions-fda-to-deny-second-indication-for-keryxs-chronic-kidney-disease-drug/ 2017-07-12T22:08:02+00:00 https://biolegacyresearch.com/rumor-alert-astrazeneca-plc-ceo-to-become-tevas-new-leader/ 2017-07-13T00:00:00+00:00 https://biolegacyresearch.com/bnumares-agb-achieves-key-milestone-identifies-candidate-metabolomic-network-for-bladder-cancer-diagnostics/ 2017-07-13T00:00:00+00:00 https://biolegacyresearch.com/merck-kgaa-to-shutter-four-sites-lay-off-200-employees/ 2017-07-13T00:00:00+00:00 https://biolegacyresearch.com/g1-therapeutics-appoints-to-board-of-directors/ 2017-07-13T00:00:00+00:00 https://biolegacyresearch.com/this-is-the-fastest-growing-cancer-biotech-no-one-really-knows-about/ 2017-07-13T00:00:00+00:00 https://biolegacyresearch.com/sanofi-availability-of-the-pre-quarterly-results-communication/ 2017-07-13T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithkline-poaches-another-top-execmdashthis-time-from-pfizer/ 2017-07-13T00:00:00+00:00 https://biolegacyresearch.com/biotime-subsidiary-agex-therapeutics-inc-appoints-ph-d-as-vp-of-new-technology-discovery/ 2017-07-13T00:00:00+00:00 https://biolegacyresearch.com/fda-panel-unanimously-endorses-novartis-ags-car-t-leukemia-drug/ 2017-07-13T00:00:00+00:00 https://biolegacyresearch.com/medidata-solutions-inc-successfully-hosts-annual-conference-series/ 2017-07-13T00:00:00+00:00 https://biolegacyresearch.com/ec-publishes-new-action-plan-for-antimicrobial-resistance/ 2017-07-13T17:47:19+00:00 https://biolegacyresearch.com/indian-drugmaker-receives-import-ban-after-drug-shortage-ends/ 2017-07-13T17:48:57+00:00 https://biolegacyresearch.com/ema-unveils-action-plan-to-support-small-and-mediuma-sized-companies/ 2017-07-13T17:49:57+00:00 https://biolegacyresearch.com/fda-updates-part-11-guidance-to-include-mobile-tech-wearables/ 2017-07-13T17:51:02+00:00 https://biolegacyresearch.com/nice-recommends-kadcyla-kyprolis-and-rejects-besponsa-coverage/ 2017-07-13T17:52:42+00:00 https://biolegacyresearch.com/tga-plans-to-auto-approve-low-risk-product-variations/ 2017-07-13T17:58:12+00:00 https://biolegacyresearch.com/congress-probing-changes-to-off-label-use-rules/ 2017-07-13T21:51:32+00:00 https://biolegacyresearch.com/advisory-committee-unanimously-recommends-avastin-herceptin-biosimilars/ 2017-07-13T21:52:40+00:00 https://biolegacyresearch.com/fda-releases-slew-of-product-specific-draft-guidances/ 2017-07-13T21:53:38+00:00 https://biolegacyresearch.com/oventus-extension-of-share-purchase-plan/ 2017-07-14T00:00:00+00:00 https://biolegacyresearch.com/sources-reveal-tesaro-is-unlikely-to-find-a-buyer/ 2017-07-14T00:00:00+00:00 https://biolegacyresearch.com/university-enterprise-laboratories-announces-partnership-with-umgc/ 2017-07-14T00:00:00+00:00 https://biolegacyresearch.com/how-astrazeneca-plcs-silence-led-to-a-4-billion-loss-overnight/ 2017-07-14T00:00:00+00:00 https://biolegacyresearch.com/sangamo-receives-fast-track-designation-from-the-fda-for-sb-318-and-sb-913-in-vivo-genome-editing-product-candidates-for-the-treatment-of-mps-i-and-mps-ii/ 2017-07-14T00:00:00+00:00 https://biolegacyresearch.com/biotech-startup-quietly-sets-up-shop-in-maryland/ 2017-07-14T00:00:00+00:00 https://biolegacyresearch.com/akcea-therapeutics-announces-pricing-of-initial-public-offering/ 2017-07-14T00:00:00+00:00 https://biolegacyresearch.com/fda-gives-nod-to-johnson-johnsons-potential-blockbuster-psoriasis-med/ 2017-07-14T00:00:00+00:00 https://biolegacyresearch.com/sartorius-stedim-biotech-supports-mainstream-adoption-of-quality-by-design/ 2017-07-14T00:00:00+00:00 https://biolegacyresearch.com/cash-strapped-alder-biopharma-secures-160-million-in-stock-sale-to-continue-operations/ 2017-07-14T00:00:00+00:00 https://biolegacyresearch.com/biogen-to-present-data-at/ 2017-07-14T00:00:00+00:00 https://biolegacyresearch.com/immunogen-announces-conference-call-to-discuss-its-second-quarter-2017-financial-results/ 2017-07-14T00:00:00+00:00 https://biolegacyresearch.com/court-rules-par-generic-infringes-on-ferrings-prepopik-patent/ 2017-07-14T23:06:48+00:00 https://biolegacyresearch.com/lilly-settles-cialis-patent-case-delaying-generic-competition-through-september-2018/ 2017-07-14T23:07:32+00:00 https://biolegacyresearch.com/fda-sponsored-report-recommends-reassessing-all-opioids-weighing-broader-impacts-in-approvals/ 2017-07-14T23:08:25+00:00 https://biolegacyresearch.com/drugmaker-cited-for-gmp-quality-issues/ 2017-07-14T23:09:28+00:00 https://biolegacyresearch.com/bbluechiip-ltdb-change-of-share-registry/ 2017-07-17T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-plc-confirms-ceo-is-staying-putmdashfor-now/ 2017-07-17T00:00:00+00:00 https://biolegacyresearch.com/inaugural-asia-pacific-gamp-data-integrity-conference-announced/ 2017-07-17T00:00:00+00:00 https://biolegacyresearch.com/safety-issues-force-the-fda-to-turn-down-amgen-ucb-sas-osteoporosis-drug/ 2017-07-17T00:00:00+00:00 https://biolegacyresearch.com/phoenix-molecular-designs-appoints-leading-oncology-expert-as-chief-scientific-officer/ 2017-07-17T00:00:00+00:00 https://biolegacyresearch.com/radius-healths-longtime-ceo-out-former-novo-nordisk-as-exec-named-new-leader/ 2017-07-17T00:00:00+00:00 https://biolegacyresearch.com/cytosorbents-expands-distribution-and-sales-of-cytosorb-to-treat-deadly-inflammation-in-panama-with-drgr/ 2017-07-17T00:00:00+00:00 https://biolegacyresearch.com/debt-ridden-valeant-dumps-another-asset-in-190-million-cash-deal/ 2017-07-17T00:00:00+00:00 https://biolegacyresearch.com/bluye-life-sciencesb-expands-global-reach-as-new-boston-rd-center-opens/ 2017-07-17T00:00:00+00:00 https://biolegacyresearch.com/strongbridge-biopharma-banks-53-million-financing-from/ 2017-07-17T00:00:00+00:00 https://biolegacyresearch.com/antriabio-announces-13-million-close-of-private-placement-transaction-and-plan-to-dose-first-patient-with-ab101-this-month/ 2017-07-18T00:00:00+00:00 https://biolegacyresearch.com/takeda-axes-sales-jobs-forces-hundreds-of-employees-to-relocate-to-boston/ 2017-07-18T00:00:00+00:00 https://biolegacyresearch.com/redhill-biopharma-to-host-second-quarter-2017-financial-results-conference-call-on-july-25-2017/ 2017-07-18T00:00:00+00:00 https://biolegacyresearch.com/2-fast-rising-biotech-stocks-with-no-competition-in-sight/ 2017-07-18T00:00:00+00:00 https://biolegacyresearch.com/veeva-systems-inc-files-suit-to-fight-unfair-business-practices-that-limit-employee-rights/ 2017-07-18T00:00:00+00:00 https://biolegacyresearch.com/puma-biotech-surges-after-the-fda-officially-approves-breast-cancer-drug/ 2017-07-18T00:00:00+00:00 https://biolegacyresearch.com/anpac-bio-medical-science-wins-global-precision-medicine-industry-award-2017-most-promising-cancer-screening-company/ 2017-07-18T00:00:00+00:00 https://biolegacyresearch.com/bgottliebb-lays-out-plans-to-attract-and-preserve-top-talent-at-the-fda/ 2017-07-18T00:00:00+00:00 https://biolegacyresearch.com/allergy-therapeutics-trading-update/ 2017-07-18T00:00:00+00:00 https://biolegacyresearch.com/clarus-ventures-wants-to-pick-up-the-tab-for-big-pharmas-rd-with-new-910-million-fund/ 2017-07-18T00:00:00+00:00 https://biolegacyresearch.com/fda-considering-further-steps-to-boost-generics-competition/ 2017-07-18T22:09:00+00:00 https://biolegacyresearch.com/senate-appropriators-move-forward-on-fda-funding/ 2017-07-18T22:11:00+00:00 https://biolegacyresearch.com/feds-say-they-are-out-of-options-to-improve-340b-transparency-and-ask-congress-to-take-action/ 2017-07-18T22:12:00+00:00 https://biolegacyresearch.com/fda-launching-drug-risk-communications-study-for-social-media/ 2017-07-18T22:14:00+00:00 https://biolegacyresearch.com/fda-hits-tubilux-pharma-for-contamination-risks-particulate-testing/ 2017-07-18T22:18:00+00:00 https://biolegacyresearch.com/vernalis-plc-year-end-trading-update-and-notice-of-full-year-results/ 2017-07-19T00:00:00+00:00 https://biolegacyresearch.com/vertex-gains-8-billion-overnight-as-cystic-fibrosis-combo-drug-wows-in-trials/ 2017-07-19T00:00:00+00:00 https://biolegacyresearch.com/bstonecalibreb-affiliate-acquires-in-vitro-diagnostics-products-provider-balpha-tec-systemsb/ 2017-07-19T00:00:00+00:00 https://biolegacyresearch.com/new-glaxosmithkline-ceo-wants-to-dump-another-business-as-it-prioritizes-pharma/ 2017-07-19T00:00:00+00:00 https://biolegacyresearch.com/mayne-pharma-appoints-executive-vice-president-at-metrics-contract-services/ 2017-07-19T00:00:00+00:00 https://biolegacyresearch.com/fda-green-lights-gileads-vosevi-with-a-black-box-warning-attached/ 2017-07-19T00:00:00+00:00 https://biolegacyresearch.com/4c-medical-tech-exceeds-8-million-convertible-note-financing-round-led-by/ 2017-07-19T00:00:00+00:00 https://biolegacyresearch.com/samsung-bioepis-emerging-as-a-strong-player-in-the-autoimmune-space/ 2017-07-19T00:00:00+00:00 https://biolegacyresearch.com/biomarin-to-host-second-quarter-2017-financial-results-conference-call-and-webcast-on-wednesday-august-2-at-430pm-et/ 2017-07-19T00:00:00+00:00 https://biolegacyresearch.com/novartis-ag-boss-updates-q2-financials-and-reaffirms-ma-strategy/ 2017-07-19T00:00:00+00:00 https://biolegacyresearch.com/fda-pilot-program-will-explore-product-tracking-systems-required-by-2023/ 2017-07-19T22:12:00+00:00 https://biolegacyresearch.com/appeals-court-restores-takedas-velcade-patent/ 2017-07-19T22:14:00+00:00 https://biolegacyresearch.com/european-commission-objects-to-teva-cephalons-pay-for-delay-deal/ 2017-07-19T22:15:00+00:00 https://biolegacyresearch.com/fda-warns-supplement-companies-over-health-claims-and-gmp-violations/ 2017-07-19T22:17:00+00:00 https://biolegacyresearch.com/regulus-announces-pricing-of-public-offering-of-common-stock/ 2017-07-20T00:00:00+00:00 https://biolegacyresearch.com/hundreds-of-jobs-to-go-as-glaxosmithkline-shutters-manufacturing-site/ 2017-07-20T00:00:00+00:00 https://biolegacyresearch.com/alcresta-snags-fda-510k-clearance-for-use-of-relizorb-in-kids/ 2017-07-20T00:00:00+00:00 https://biolegacyresearch.com/ablynx-seals-nanobody-rd-deal-worth-2-8-billion-with-drug-giant-sanofi/ 2017-07-20T00:00:00+00:00 https://biolegacyresearch.com/biotime-to-announce-second-quarter-2017-results-on-august-2-2017/ 2017-07-20T00:00:00+00:00 https://biolegacyresearch.com/roche-reprioritizes-pipeline-kicks-leukemia-and-lung-cancer-drug-med-back-to-oryzon-genomics/ 2017-07-20T00:00:00+00:00 https://biolegacyresearch.com/first-patients-treated-with-viewrays-mridian-linac-system-at/ 2017-07-20T00:00:00+00:00 https://biolegacyresearch.com/most-common-mistake-scientists-make-when-applying-for-a-job/ 2017-07-20T00:00:00+00:00 https://biolegacyresearch.com/exelixis-announces-settlement-of-dispute-with-genentech-regarding-companies-collaboration-agreement-for-cobimetinib/ 2017-07-20T00:00:00+00:00 https://biolegacyresearch.com/can-this-region-become-the-countrys-next-big-biotech-hub-for-jobs/ 2017-07-20T00:00:00+00:00 https://biolegacyresearch.com/fda-funding-bill-advances-in-the-senate/ 2017-07-20T22:59:00+00:00 https://biolegacyresearch.com/merck-pfizer-corning-unveil-new-pharmaceutical-glass-at-the-white-house/ 2017-07-20T23:01:00+00:00 https://biolegacyresearch.com/phrma-advamed-say-fdas-intended-use-final-rule-could-chill-speech/ 2017-07-20T23:04:00+00:00 https://biolegacyresearch.com/fda-extends-expiration-dates-of-sodium-bicarbonate-injectables-in-shortage/ 2017-07-20T23:06:00+00:00 https://biolegacyresearch.com/tissue-regenix-banks-52-million-and-pays-30-million-for-texas/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/corning-merck-co-and-pfizer-to-invest-4-billion-and-create-4000-new-jobs-in-the-u-s/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/innocoll-announcement-relating-to-the-outcome-of-the-court-sanction-hearing/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/10-biotechs-tackling-form-of-aggressive-brain-cancer/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/aceto-subsidiary-rising-pharma-announces-product-launches/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/endo-international-slashes-875-jobs-and-will-shutter-alabama-facilities/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/ligand-to-report-second-quarter-2017-results-on-august-7th/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/3-sizzling-hot-biotech-stocks-only-likely-to-get-hotter/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/bkdab-release-meeting-medical-software-regulatory-requirements/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/teligent-announces-fda-approval-of-erythromycin-topical-gel-usp-2/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-plc-ceo-breaks-silence-on-teva-rumors-urges-staff-to-remain-focused-in-leaked-memo/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/prime-therapeutics-urges-caution-on-mandates-of-abuse-deterrent-formulations-of-opioids-citing-value-concerns/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/bteresa-l-klineb-joins-intersect-ents-board-of-directors/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/ironwood-to-host-second-quarter-2017-investor-update-call/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/spinalcyte-llc-receives-new-japanese-patent/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/bvanc-pharmaceuticalsb-announces-non-brokered-private-placement/ 2017-07-21T00:00:00+00:00 https://biolegacyresearch.com/chmp-recommends-11-medicines-for-approval-including-five-orphan-drugs/ 2017-07-21T22:22:00+00:00 https://biolegacyresearch.com/fda-grants-tentative-approval-to-mercks-insulin-glargine-copycat/ 2017-07-21T22:23:00+00:00 https://biolegacyresearch.com/ptab-upholds-five-pfizer-ucb-patents-for-toviaz/ 2017-07-21T22:25:00+00:00 https://biolegacyresearch.com/ema-reflects-on-one-year-of-its-prime-designation/ 2017-07-21T22:27:00+00:00 https://biolegacyresearch.com/mhra-flags-data-integrity-recordkeeping-in-new-gcp-inspection-report/ 2017-07-21T22:28:00+00:00 https://biolegacyresearch.com/fdanews-joins-wirb-copernicus-group/ 2017-07-21T22:30:00+00:00 https://biolegacyresearch.com/relay-therapeutics-names-vice-president-of-corporate-development-and-strategy/ 2017-07-24T00:00:00+00:00 https://biolegacyresearch.com/theratechnologies-announces-new-findings-with-the-investigational-antiretroviral-ibalizumab-and-with-egrifta-tesamorelin-for-injection/ 2017-07-24T00:00:00+00:00 https://biolegacyresearch.com/alimera-sciences-to-report-second-quarter-2017-financial-results-on-august-2nd-2017/ 2017-07-24T00:00:00+00:00 https://biolegacyresearch.com/mitsubishi-tanabe-coughs-up-1-1-billion-cash-for-this-parkinsons-biotech/ 2017-07-24T00:00:00+00:00 https://biolegacyresearch.com/sqi-diagnostics-partners-with-mcmaster-university-to-co-develop-instant-immunoassay-testing-technology/ 2017-07-24T00:00:00+00:00 https://biolegacyresearch.com/boehringer-ingelheim-aims-for-300-new-bay-area-jobs-with-217-million-expansion/ 2017-07-24T00:00:00+00:00 https://biolegacyresearch.com/mabvax-therapeutics-board-of-directors-authorizes-the-company-to-explore-strategic-alternatives/ 2017-07-24T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-nektar-inks-400-million-autoimmune-disease-pact-with-eli-lilly/ 2017-07-24T00:00:00+00:00 https://biolegacyresearch.com/kindred-bio-to-announce-second-quarter-2017-financial-results/ 2017-07-24T00:00:00+00:00 https://biolegacyresearch.com/fda-to-allow-consent-waivers-in-minimal-risk-studies/ 2017-07-24T22:08:00+00:00 https://biolegacyresearch.com/democrats-outline-better-deal-agenda-targeting-high-drug-prices/ 2017-07-24T22:10:00+00:00 https://biolegacyresearch.com/samsung-bioepis-merck-launch-remicade-biosimilar-early-following-scotus-decision/ 2017-07-24T22:11:00+00:00 https://biolegacyresearch.com/fda-issues-revised-ich-risk-benefit-submission-guidance/ 2017-07-24T22:13:00+00:00 https://biolegacyresearch.com/merck-faces-liability-lawsuit-from-18-patients-over-shingles-vaccine/ 2017-07-24T22:15:00+00:00 https://biolegacyresearch.com/reagan-udall-foundation-launches-directory-of-manufacturer-expanded-access-policies/ 2017-07-24T22:16:00+00:00 https://biolegacyresearch.com/massachusetts-exosome-diagnostics-snags-30-million/ 2017-07-25T00:00:00+00:00 https://biolegacyresearch.com/teva-announces-the-launch-of-generic-vagifem-in-the-united-states/ 2017-07-25T00:00:00+00:00 https://biolegacyresearch.com/eli-lilly-shakes-up-cancer-rd-strategy-seeks-new-home-for-seven-pipeline-drugs/ 2017-07-25T00:00:00+00:00 https://biolegacyresearch.com/ptc-therapeutics-to-host-conference-call-to-discuss-second-quarter-financial-results/ 2017-07-25T00:00:00+00:00 https://biolegacyresearch.com/google-quietly-invests-in-this-cancer-testing-startup-builds-lab-on-verily-campus-to-sweeten-deal/ 2017-07-25T00:00:00+00:00 https://biolegacyresearch.com/horizon-pharma-launches-cgd-connections-to-deliver-support-and-resources-created-by-and-for-the-chronic-granulomatous-disease-cgd-community/ 2017-07-25T00:00:00+00:00 https://biolegacyresearch.com/japanese-pharma-giant-astellas-sets-up-shop-in-cambridge/ 2017-07-25T00:00:00+00:00 https://biolegacyresearch.com/bend-aids-coalitionb-creates-unprecedented-collaboration-at-tipping-point-in-aids-epidemic/ 2017-07-25T00:00:00+00:00 https://biolegacyresearch.com/bvenatorx-pharmab-banks-42-million-to-advance-antibiotics-pipeline/ 2017-07-25T00:00:00+00:00 https://biolegacyresearch.com/blesaffreb-invests-in-intralytix-a-u-s-biotechnology-company/ 2017-07-25T00:00:00+00:00 https://biolegacyresearch.com/bviriomb-obtains-first-market-approval-of-elsulfavirine-elpida-for-treatment-of-hiv-1-infection-in-russia/ 2017-07-25T00:00:00+00:00 https://biolegacyresearch.com/fda-finalizes-generic-qa-guidance-as-sun-sets-on-gdufa-i/ 2017-07-25T22:02:49+00:00 https://biolegacyresearch.com/abbvie-ordered-to-pay-150-million-to-androgel-user-for-heart-attack/ 2017-07-25T22:03:00+00:00 https://biolegacyresearch.com/missouri-to-be-last-state-to-implement-a-pdmp-following-governors-order/ 2017-07-25T22:06:00+00:00 https://biolegacyresearch.com/ema-revises-10-year-old-guideline-on-first-in-human-clinical-trials/ 2017-07-25T22:07:00+00:00 https://biolegacyresearch.com/lonza-inc-pharmabiotech-launches-ibex-solutions-an-innovative-new-concept-in-biological-manufacturing-and-development/ 2017-07-26T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithkline-ceo-kills-30-pre-clinical-and-clinical-programs/ 2017-07-26T00:00:00+00:00 https://biolegacyresearch.com/tesaro-to-announce-second-quarter-2017-financial-results-on-august-8-2017/ 2017-07-26T00:00:00+00:00 https://biolegacyresearch.com/fda-head-postpones-layoff-notices-of-thousands-of-employees/ 2017-07-26T00:00:00+00:00 https://biolegacyresearch.com/flex-pharma-to-report-second-quarter-2017-results-on-august-2-2017/ 2017-07-26T00:00:00+00:00 https://biolegacyresearch.com/death-count-rises-for-patients-on-dynavaxs-hep-b-vaccine-but-overall-rate-was-low-says-the-fda/ 2017-07-26T00:00:00+00:00 https://biolegacyresearch.com/surmodics-receives-ide-approval-to-initiate-pivotal-trial-of-the-surveil-drug-coated-balloon/ 2017-07-26T00:00:00+00:00 https://biolegacyresearch.com/heads-up-startups-silicon-valley-vc-firmmdashwith-an-appetite-for-biotechmdashnabs-record-800-million-fund/ 2017-07-26T00:00:00+00:00 https://biolegacyresearch.com/blueprint-medicines-to-report-second-quarter-2017-financial-results-on-wednesday-august-2-2017/ 2017-07-26T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-with-positive-technical-stock-readouts-ahead-of-q2-reports/ 2017-07-26T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-reassures-staff-as-user-fee-deadline-approaches/ 2017-07-26T22:21:01+00:00 https://biolegacyresearch.com/celgene-settles-280-million-lawsuit-over-off-label-marketing-campaigns/ 2017-07-26T22:22:00+00:00 https://biolegacyresearch.com/fda-advisory-panel-votes-down-intellipharmaceutics-abuse-deterrent-opioid/ 2017-07-26T22:22:01+00:00 https://biolegacyresearch.com/eleven-generic-companies-must-face-class-action-pricing-lawsuit/ 2017-07-26T22:23:53+00:00 https://biolegacyresearch.com/maryland-drugmaker-warned-on-sterility/ 2017-07-26T22:25:10+00:00 https://biolegacyresearch.com/neuralstem-announces-pricing-of-public-offering-of-common-stock-and-warrants/ 2017-07-27T00:00:00+00:00 https://biolegacyresearch.com/alexion-redefines-rd-strategy-discontinues-programs-and-kills-deals-with-moderna-blueprint-and-arbutus-biopharma/ 2017-07-27T00:00:00+00:00 https://biolegacyresearch.com/gilead-announces-second-quarter-2017-financial-results/ 2017-07-27T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-plc-seals-a-8-5-billion-rd-cancer-tie-up-with-merck-co/ 2017-07-27T00:00:00+00:00 https://biolegacyresearch.com/alkermes-reports-second-quarter-2017-financial-results/ 2017-07-27T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-plc-loses-10-billion-in-value-as-long-awaited-mystic-trial-disappoints/ 2017-07-27T00:00:00+00:00 https://biolegacyresearch.com/repligen-to-report-second-quarter-2017-financial-results/ 2017-07-27T00:00:00+00:00 https://biolegacyresearch.com/astellas-takes-a-387-million-loss-as-it-shuts-down-socals-agensys-inc/ 2017-07-27T00:00:00+00:00 https://biolegacyresearch.com/bj-p-morganbs-bcommercial-bankb-expands-life-sciences-team-to-serve-fast-growing-industry-team-adds-experienced-bankers-and-expands-to-key-u-s-markets/ 2017-07-27T00:00:00+00:00 https://biolegacyresearch.com/bavarian-nordic-rockets-on-expanded-846-million-hiv-hepatitis-b-deal-with-johnson-johnson/ 2017-07-27T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-flags-fdas-untapped-authority-to-fight-high-prices-and-rems-abuses/ 2017-07-27T21:58:06+00:00 https://biolegacyresearch.com/mccaskill-broadens-opioid-investigation-to-more-manufacturers-distributors/ 2017-07-27T21:58:51+00:00 https://biolegacyresearch.com/fda-taking-nominations-for-list-of-difficult-to-compound-drugs/ 2017-07-27T22:01:28+00:00 https://biolegacyresearch.com/exactech-q2-revenue-67-3-million-on-continuing-strong-extremities-revenue/ 2017-07-28T00:00:00+00:00 https://biolegacyresearch.com/fda-calls-roches-leukemia-drug-a-breakthrough/ 2017-07-28T00:00:00+00:00 https://biolegacyresearch.com/accenture-develops-artificial-intelligence-powered-solution-to-help-improve-how-visually-impaired-people-live-and-work/ 2017-07-28T00:00:00+00:00 https://biolegacyresearch.com/amazon-has-top-secret-1492-unit-working-on-healthcare-and-telemedicine/ 2017-07-28T00:00:00+00:00 https://biolegacyresearch.com/kamada-pre-announces-certain-preliminary-financial-results-for-second-quarter-and-first-six-months-of-2017/ 2017-07-28T00:00:00+00:00 https://biolegacyresearch.com/illumina-accelerator-in-the-bay-area-makes-room-for-5-new-biotech-startups/ 2017-07-28T00:00:00+00:00 https://biolegacyresearch.com/tandem-diabetes-care-reports-second-quarter-2017-financial-results/ 2017-07-28T00:00:00+00:00 https://biolegacyresearch.com/some-glaxosmithkline-critics-would-prefer-broke-up-the-company/ 2017-07-28T00:00:00+00:00 https://biolegacyresearch.com/la-jolla-pharma-announces-financial-results-for-the-three-and-six-months-ended-june-30-2017-and-recent-corporate-progress/ 2017-07-28T00:00:00+00:00 https://biolegacyresearch.com/cmos-cringe-as-glaxosmithkline-will-be-cutting-its-use-by-25/ 2017-07-28T00:00:00+00:00 https://biolegacyresearch.com/senates-aca-repeal-blocked-by-murkowski-collins-mccain/ 2017-07-28T22:43:34+00:00 https://biolegacyresearch.com/fda-vaccine-panel-says-dynavaxs-hepislav-b-meets-safety-requirements/ 2017-07-28T22:45:08+00:00 https://biolegacyresearch.com/district-court-issues-permanent-injunction-to-seller-of-unapproved-dermatological-drugs/ 2017-07-28T22:46:12+00:00 https://biolegacyresearch.com/sterile-drugmakers-sterility-procedures-found-lacking/ 2017-07-28T22:47:27+00:00 https://biolegacyresearch.com/hamilton-company-releases-latest-addition-to-psd4-precision-syringe-drive-product-line/ 2017-07-31T00:00:00+00:00 https://biolegacyresearch.com/fda-calls-astrazeneca-plc-and-medimmunes-imfinzi-a-breakthrough/ 2017-07-31T00:00:00+00:00 https://biolegacyresearch.com/study-compares-performance-of-masimo-acoustic-respiration-rate-rra-and-nellcor-plethysmographic-respiration-rate-in-volunteers/ 2017-07-31T00:00:00+00:00 https://biolegacyresearch.com/following-recent-death-invivo-therapeutics-temporarily-halts-enrollment-in-inspire-study/ 2017-07-31T00:00:00+00:00 https://biolegacyresearch.com/mettler-toledo-to-exhibit-at/ 2017-07-31T00:00:00+00:00 https://biolegacyresearch.com/fda-raises-big-safety-concerns-with-johnson-johnsons-arthritis-drug-sirukumab/ 2017-07-31T00:00:00+00:00 https://biolegacyresearch.com/bubm-medicabs-boncology-and-society-for-integrative-oncology-siob-announce-partnership/ 2017-07-31T00:00:00+00:00 https://biolegacyresearch.com/bristol-myers-squibb-clovis-oncology-ink-pact-to-marry-their-pd-1parp-drugs-in-phase-ii-and-iii/ 2017-07-31T00:00:00+00:00 https://biolegacyresearch.com/onxeo-reports-first-half-2017-results-and-business-update/ 2017-07-31T00:00:00+00:00 https://biolegacyresearch.com/4-hot-biotech-stocks-in-2017/ 2017-07-31T00:00:00+00:00 https://biolegacyresearch.com/white-house-opioid-commission-recommends-national-state-of-emergency/ 2017-07-31T22:22:20+00:00 https://biolegacyresearch.com/fda-withdraws-9-proposed-fda-regulations-and-rules-as-part-of-trump-deregulation-effort/ 2017-07-31T22:23:58+00:00 https://biolegacyresearch.com/bio-says-bsufa-ii-appraisal-must-include-third-party-evaluator/ 2017-07-31T22:24:23+00:00 https://biolegacyresearch.com/intellipharmaceutics-hit-with-lawsuit-for-allegedly-hyping-rexista/ 2017-07-31T22:25:34+00:00 https://biolegacyresearch.com/pto-grants-additional-reviews-of-herceptin-patents-after-hospira-challenges/ 2017-07-31T22:26:38+00:00 https://biolegacyresearch.com/agios-celgene-win-early-fda-approval-for-new-cancer-drug/ 2017-08-01T00:00:00+00:00 https://biolegacyresearch.com/nemaura-medical-develops-rechargeable-transmitter-for-sugarbeat/ 2017-08-01T00:00:00+00:00 https://biolegacyresearch.com/8-pdufa-dates-to-watch-in-august/ 2017-08-01T00:00:00+00:00 https://biolegacyresearch.com/bttp-plcb-showcases-puckdx-developments-at-69th-aacc-annual-scientific-meeting-clinical-lab-expo/ 2017-08-01T00:00:00+00:00 https://biolegacyresearch.com/pixarbio-slashed-headcount-evicted-from-medford-headquarters/ 2017-08-01T00:00:00+00:00 https://biolegacyresearch.com/integrated-dna-technologies-launches-first-cas9-enzyme-that-drastically-reduces-crispr-off-target-effects-without-significant-loss-of-on-target-activity/ 2017-08-01T00:00:00+00:00 https://biolegacyresearch.com/pharma-giant-astrazeneca-plc-scores-another-fda-breakthrough/ 2017-08-01T00:00:00+00:00 https://biolegacyresearch.com/boneservice-agb-announces-the-appointment-of-bstephen-l-elliottb-as-president-boneservice-inc-north-americab/ 2017-08-01T00:00:00+00:00 https://biolegacyresearch.com/massachusetts-homology-medicines-snags-83-5m-to-advance-amendr-into-human-trials/ 2017-08-01T00:00:00+00:00 https://biolegacyresearch.com/w-l-gore-associates-release-gore-viatorr-tips-endoprosthesis-with-controlled-expansion-may-reduce-portal-hypertension-readmissions-in-ongoing-study/ 2017-08-01T00:00:00+00:00 https://biolegacyresearch.com/fda-guidelines-seek-to-speed-development-of-antibacterial-drugs/ 2017-08-01T21:48:08+00:00 https://biolegacyresearch.com/mcconnell-calls-for-vote-on-user-fees-before-senate-leaves-for-recess/ 2017-08-01T21:49:07+00:00 https://biolegacyresearch.com/fda-warns-four-compounders-for-lacking-valid-individual-prescriptions/ 2017-08-01T21:49:55+00:00 https://biolegacyresearch.com/district-court-tosses-liability-suit-against-pfizer-bms-eliquis/ 2017-08-01T21:50:48+00:00 https://biolegacyresearch.com/pharma-leaders-call-nation-states-top-cybersecurity-threat/ 2017-08-01T21:51:34+00:00 https://biolegacyresearch.com/ocular-therapeutix-to-slash-jobs-after-fda-rejection/ 2017-08-02T00:00:00+00:00 https://biolegacyresearch.com/keystone-heart-to-accelerate-trials-for-a-new-advanced-cerebral-embolic-protection-device/ 2017-08-02T00:00:00+00:00 https://biolegacyresearch.com/4-clinical-projects-shelved-from-pfizers-pipeline/ 2017-08-02T00:00:00+00:00 https://biolegacyresearch.com/boost-for-as-announce-first-award-winners/ 2017-08-02T00:00:00+00:00 https://biolegacyresearch.com/why-you-want-to-keep-this-small-2-biotech-stock-on-your-radar/ 2017-08-02T00:00:00+00:00 https://biolegacyresearch.com/alnylam-to-webcast-conference-call-discussing-second-quarter-2017-financial-results/ 2017-08-02T00:00:00+00:00 https://biolegacyresearch.com/former-biotech-ceo-accused-of-defrauding-investors/ 2017-08-02T00:00:00+00:00 https://biolegacyresearch.com/nightstarx-appoints-as-chief-development-officer/ 2017-08-02T00:00:00+00:00 https://biolegacyresearch.com/seattle-genetics-nabs-bristol-myers-squibbs-bothell-mfg-facility-plans-to-offer-jobs-to-current-employees/ 2017-08-02T00:00:00+00:00 https://biolegacyresearch.com/samumeds-osteoarthritis-research-selected-for-an-oral-presentation-at-a-conference/ 2017-08-02T00:00:00+00:00 https://biolegacyresearch.com/fda-releases-draft-labeling-guidance-on-child-resistant-packaging/ 2017-08-02T19:40:52+00:00 https://biolegacyresearch.com/daiichi-sankyo-settles-benicar-liability-suits-for-300-million/ 2017-08-02T19:41:47+00:00 https://biolegacyresearch.com/ema-prioritizes-tasks-in-preparing-for-brexit-and-possible-staff-losses/ 2017-08-02T19:42:47+00:00 https://biolegacyresearch.com/fda-warns-dietary-supplement-companies-on-ingredients-product-claims/ 2017-08-02T19:47:26+00:00 https://biolegacyresearch.com/fda-committee-votes-down-janssens-plivensia-arthritis-drug-citing-safety-concerns/ 2017-08-02T19:52:45+00:00 https://biolegacyresearch.com/amerisourcebergen-reports-third-quarter-fiscal-year-2017-results/ 2017-08-03T00:00:00+00:00 https://biolegacyresearch.com/fda-advisory-panel-votes-against-approval-of-johnson-johnsons-sirukumab/ 2017-08-03T00:00:00+00:00 https://biolegacyresearch.com/zymeworks-appoints-dr-to-its-board-of-directors/ 2017-08-03T00:00:00+00:00 https://biolegacyresearch.com/biotech-startup-nabs-9m/ 2017-08-03T00:00:00+00:00 https://biolegacyresearch.com/sygnis-reports-financial-results-for-the-second-quarter-and-first-six-months-of-2017/ 2017-08-03T00:00:00+00:00 https://biolegacyresearch.com/regeneron-to-terminate-its-antibody-discovery-pact-with-sanofi/ 2017-08-03T00:00:00+00:00 https://biolegacyresearch.com/bruker-corporation-announces-acquisition-of-field-portable-platform-for-fast-and-universal-immunoassay-detection-of-bacteria-viruses-and-toxins/ 2017-08-03T00:00:00+00:00 https://biolegacyresearch.com/johnson-johnsons-imbruvica-scores-expanded-fda-approval-for-chronic-graft-vs-host-disease/ 2017-08-03T00:00:00+00:00 https://biolegacyresearch.com/exelixis-announces-second-quarter-2017-financial-results-and-provides-corporate-update/ 2017-08-03T00:00:00+00:00 https://biolegacyresearch.com/former-google-exec-steps-down-as-grail-ceo/ 2017-08-03T00:00:00+00:00 https://biolegacyresearch.com/senate-sends-fda-user-fee-bill-to-the-president-approves-federal-right-to-try-legislation/ 2017-08-03T23:31:44+00:00 https://biolegacyresearch.com/fda-advisory-committee-backs-new-indication-for-pfizers-xeljanz/ 2017-08-03T23:32:32+00:00 https://biolegacyresearch.com/abbvie-suit-claims-humira-patent-violations-by-boehringer-ingelheim/ 2017-08-03T23:33:26+00:00 https://biolegacyresearch.com/cambrex-corporation-reports-second-quarter-2017-financial-results/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/this-boston-biotech-just-got-scooped-up-for-300m-by-bristol-myers-squibb/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/bone-biologics-announces-appointment-of-to-companys-board-of-directors/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/dynavax-shares-plunge-on-delayed-fda-decision-for-hep-b-vaccine-heplisav/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/mallinckrodt-reports-second-quarter-2017-results/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/abbvie-wins-fda-approval-for-the-first-ever-drug-to-treat-all-forms-of-hep-c/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/accuray-inc-release-first-radixact-system-research-results-presented-at-the/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/united-therapeutics-shares-surge-on-report-of-bids-for-company/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/juniper-pharma-reports-second-quarter-2017-financial-and-operating-results/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithkline-to-shift-neuro-rd-out-of-china-to-philadelphia-research-hub/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/capricor-second-quarter-2017-update-webcast-and-conference-call-scheduled-for-thursday-august-10/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/pharma-scores-big-win-to-ink-fda-user-fee-bill-saving-5000-jobs/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/bmadhuri-hegde-phdb-is-elected-to-the-board-of-the-bacmg-foundation-for-genetic-and-genomic-medicineb/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/mirati-therapeutics-reports-second-quarter-2017-financial-results/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/medicalsystem-biotechnology-to-sell-49-pct-stake-in-hong-kong-based-unit-for-hk-90-7-million/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/glycomimetics-reports-program-updates-and-second-quarter-2017-results/ 2017-08-04T00:00:00+00:00 https://biolegacyresearch.com/merck-and-samsung-bioepis-launch-biosimilar-early-after-scotus-ruling/ 2017-08-04T20:41:45+00:00 https://biolegacyresearch.com/avastin-herceptin-biosimilars-get-oks-from-fda-advisory-committee/ 2017-08-04T20:43:08+00:00 https://biolegacyresearch.com/lilly-settles-on-cialis-patent-pushing-generics-to-september-2018/ 2017-08-04T20:47:29+00:00 https://biolegacyresearch.com/fda-launches-device-software-pre-certification-pilot/ 2017-08-04T21:01:11+00:00 https://biolegacyresearch.com/whitehall-manufacturing-draws-fda-warning-for-therapy-devices/ 2017-08-04T21:01:36+00:00 https://biolegacyresearch.com/national-biological-draws-warning-for-nonconformance-complaints/ 2017-08-04T21:02:55+00:00 https://biolegacyresearch.com/fda-exempts-1003-class-ii-devices-from-510k-regs-but-not-gmps/ 2017-08-04T21:03:18+00:00 https://biolegacyresearch.com/brazil-adds-ireland-as-mdsap-accredited-quality-auditor/ 2017-08-04T21:04:21+00:00 https://biolegacyresearch.com/what-device-manufacturers-can-learn-from-fdas-inspection-data/ 2017-08-04T21:04:49+00:00 https://biolegacyresearch.com/483-roundup-six-devicemakers-cited-for-capa-other-deficiencies/ 2017-08-04T21:05:57+00:00 https://biolegacyresearch.com/fda-announces-recall-for-penumbra-revascularization-device/ 2017-08-04T21:06:23+00:00 https://biolegacyresearch.com/fda-finalizes-48-product-specific-bioequivalence-guidances/ 2017-08-04T22:42:30+00:00 https://biolegacyresearch.com/drug-compounder-shut-down-in-response-to-fda-complaint-of-potential-contamination/ 2017-08-04T22:43:33+00:00 https://biolegacyresearch.com/ema-calls-for-special-approach-for-tracking-pediatric-drugs/ 2017-08-04T22:44:29+00:00 https://biolegacyresearch.com/ema-seeks-comments-on-planned-nonclinical-guidance-for-radiopharmaceuticals/ 2017-08-04T22:45:23+00:00 https://biolegacyresearch.com/fda-hits-fusion-iv-for-incomplete-labeling-environmental-monitoring/ 2017-08-04T22:46:21+00:00 https://biolegacyresearch.com/aeterna-zentaris-to-announce-second-quarter-2017-financial-and-operating-results-on-august-10-2017/ 2017-08-07T00:00:00+00:00 https://biolegacyresearch.com/new-ceo-takes-over-rapamycin-leads-funding-round-with-plans-for-ind/ 2017-08-07T00:00:00+00:00 https://biolegacyresearch.com/medidata-solutions-inc-earns-recognition-as-leading-innovative-company-and-a-great-place-to-work/ 2017-08-07T00:00:00+00:00 https://biolegacyresearch.com/san-diego-based-biotech-expands-for-future-growth-and-top-talent/ 2017-08-07T00:00:00+00:00 https://biolegacyresearch.com/nabriva-reports-second-quarter-2017-financial-results-and-recent-corporate-highlights/ 2017-08-07T00:00:00+00:00 https://biolegacyresearch.com/acorda-investor-urges-for-company-to-explore-sale/ 2017-08-07T00:00:00+00:00 https://biolegacyresearch.com/fresenius-medical-care-to-acquire-nxstage-to-strengthen-its-vertically-integrated-dialysis-business/ 2017-08-07T00:00:00+00:00 https://biolegacyresearch.com/gemphire-shares-drop-on-disappointing-phase-ii-results-for-ldl-drug/ 2017-08-07T00:00:00+00:00 https://biolegacyresearch.com/eleven-bio-to-report-second-quarter-2017-financial-results-on-monday-august-14-2017/ 2017-08-07T00:00:00+00:00 https://biolegacyresearch.com/vernalis-hit-by-u-s-setback-for-cough-and-cold-drug-ccp-08/ 2017-08-07T00:00:00+00:00 https://biolegacyresearch.com/warning-letter-roundup-five-firms-cited-for-gmps-other-issues/ 2017-08-07T20:50:21+00:00 https://biolegacyresearch.com/fda-warns-supplement-companies-over-drug-claims-gmp-violations/ 2017-08-07T20:52:12+00:00 https://biolegacyresearch.com/ema-updates-guidelines-for-postmarket-studies-and-variations/ 2017-08-07T20:53:27+00:00 https://biolegacyresearch.com/ansm-says-chinese-drugmaker-falsified-gmp-documents/ 2017-08-07T20:54:24+00:00 https://biolegacyresearch.com/fda-cites-arj-infusion-services-over-gmps/ 2017-08-07T21:00:09+00:00 https://biolegacyresearch.com/iba-molecular-north-america-flagged-for-gmp-quality-issues/ 2017-08-07T21:01:01+00:00 https://biolegacyresearch.com/appeals-panel-reinstates-accutane-liability-suits-against-roche/ 2017-08-07T22:25:56+00:00 https://biolegacyresearch.com/anda-submissions-top-1000-with-two-months-to-go-in-fy-2017/ 2017-08-07T22:26:49+00:00 https://biolegacyresearch.com/nice-finds-keytruda-not-cost-effective-in-bladder-cancer/ 2017-08-07T22:27:37+00:00 https://biolegacyresearch.com/teva-sued-by-hedge-funds-for-delaying-disclosure-of-doj-price-fixing-subpoena/ 2017-08-07T22:28:29+00:00 https://biolegacyresearch.com/ema-to-outline-approach-to-eudravigilance-upgrade/ 2017-08-07T22:29:17+00:00 https://biolegacyresearch.com/concert-pharma-reports-second-quarter-2017-financial-results-and-provides-company-update/ 2017-08-08T00:00:00+00:00 https://biolegacyresearch.com/bay-area-galena-biopharma-merges-with-oncology-focused-biopharma-in-all-stock-deal/ 2017-08-08T00:00:00+00:00 https://biolegacyresearch.com/abbott-diabetes-care-release-freestyle-libre-system-for-people-with-diabetes-available-for-pre-order-in-canada/ 2017-08-08T00:00:00+00:00 https://biolegacyresearch.com/regeneron-heading-for-another-hiring-ramp/ 2017-08-08T00:00:00+00:00 https://biolegacyresearch.com/invivo-therapeutics-to-present-at-s-37th-annual-growth-conference/ 2017-08-08T00:00:00+00:00 https://biolegacyresearch.com/aclaris-scoops-up-st-louis-startup-in-deal-worth-up-to-100m/ 2017-08-08T00:00:00+00:00 https://biolegacyresearch.com/executives-of-juno-under-investigation/ 2017-08-08T00:00:00+00:00 https://biolegacyresearch.com/esperion-stock-gains-on-strong-phase-ii-data/ 2017-08-08T00:00:00+00:00 https://biolegacyresearch.com/zoetis-announces-second-quarter-2017-results/ 2017-08-08T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-biomarin-expands-with-the-worlds-first-and-largest-gene-therapy-manufacturing-plant/ 2017-08-08T00:00:00+00:00 https://biolegacyresearch.com/vaccine-for-addiction-touted-by-price-as-a-potential-solution-to-opioid-crisis/ 2017-08-08T22:31:58+00:00 https://biolegacyresearch.com/dea-proposes-scaling-back-national-manufacturing-of-opioids-and-other-controlled-drugs/ 2017-08-08T22:32:51+00:00 https://biolegacyresearch.com/fda-flags-minor-cmc-changes-that-only-require-an-annual-report/ 2017-08-08T22:33:52+00:00 https://biolegacyresearch.com/fda-eases-expiration-date-requirements-for-repackaged-solid-oral-dosage-drugs/ 2017-08-08T22:34:54+00:00 https://biolegacyresearch.com/emas-prac-recommends-new-label-warnings-for-several-products/ 2017-08-08T22:35:56+00:00 https://biolegacyresearch.com/fda-warns-canadian-drugmaker-over-gmps/ 2017-08-08T22:36:51+00:00 https://biolegacyresearch.com/achillion-reports-second-quarter-2017-financial-results-and-proof-of-concept-with-a-first-in-class-oral-factor-d-inhibitor/ 2017-08-09T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-ardelyx-slashes-28-of-workforce-in-restructuring/ 2017-08-09T00:00:00+00:00 https://biolegacyresearch.com/bhip-innovation-technologyb-initiates-clinical-trial-of-its-novel-hip-replacement-system-for-the-treatment-of-total-hip-arthroplasty/ 2017-08-09T00:00:00+00:00 https://biolegacyresearch.com/pharma-bro-s-new-startup-is-hiring/ 2017-08-09T00:00:00+00:00 https://biolegacyresearch.com/iovance-biotherapeutics-appoints-as-chief-financial-officer/ 2017-08-09T00:00:00+00:00 https://biolegacyresearch.com/drumroll-new-company-launched/ 2017-08-09T00:00:00+00:00 https://biolegacyresearch.com/pentax-medical-launches-new-slim-linear-ultrasound-endoscope/ 2017-08-09T00:00:00+00:00 https://biolegacyresearch.com/zeria-pharmaceutical-employees-death-was-job-related/ 2017-08-09T00:00:00+00:00 https://biolegacyresearch.com/omeros-reports-second-quarter-2017-financial-results/ 2017-08-09T00:00:00+00:00 https://biolegacyresearch.com/race-heats-up-as-mallinckrodt-gets-bids/ 2017-08-09T00:00:00+00:00 https://biolegacyresearch.com/fda-forms-senior-level-generic-competition-working-group/ 2017-08-09T21:51:28+00:00 https://biolegacyresearch.com/new-hampshire-sues-maker-of-oxycontin-claims-deceptive-marketing-of-opioid/ 2017-08-09T21:52:57+00:00 https://biolegacyresearch.com/ema-guide-outlines-steps-taken-by-multinational-review-team-leaders/ 2017-08-09T21:53:23+00:00 https://biolegacyresearch.com/nice-guidance-links-cost-effectiveness-of-osteoporosis-treatments-with-fracture-risk/ 2017-08-09T21:54:57+00:00 https://biolegacyresearch.com/pharmatech-facility-cited-by-fda/ 2017-08-09T21:55:20+00:00 https://biolegacyresearch.com/pharma-giant-bristol-myers-squibb-plans-layoffs-effective-oct-6/ 2017-08-10T00:00:00+00:00 https://biolegacyresearch.com/biocept-announces-private-placement-of-2-2-million-of-common-stock-with/ 2017-08-10T00:00:00+00:00 https://biolegacyresearch.com/galapagos-phase-ii-results-with-glpg1690-are-extremely-exciting/ 2017-08-10T00:00:00+00:00 https://biolegacyresearch.com/morphosys-ag-to-present-at-upcoming-investor-conferences/ 2017-08-10T00:00:00+00:00 https://biolegacyresearch.com/former-ptc-therapeutics-exec-jumps-ship-to-orchard-therapeutics-as-ceo/ 2017-08-10T00:00:00+00:00 https://biolegacyresearch.com/co-diagnostics-to-undergo-iso-134852016-audit/ 2017-08-10T00:00:00+00:00 https://biolegacyresearch.com/celgene-revamps-pact-with-bay-area-biotech-no-acquisition-coming/ 2017-08-10T00:00:00+00:00 https://biolegacyresearch.com/nemaura-medical-reports-first-quarter-2017-financial-results/ 2017-08-10T00:00:00+00:00 https://biolegacyresearch.com/egalet-cuts-workforce-by-40-in-expense-reduction-plan/ 2017-08-10T00:00:00+00:00 https://biolegacyresearch.com/bconfirmmdxb-study-provides-further-validation-of-epigenetic-risk-profile/ 2017-08-10T00:00:00+00:00 https://biolegacyresearch.com/emas-prac-suggests-restricting-zinbryta-in-certain-ms-patients/ 2017-08-10T20:13:49+00:00 https://biolegacyresearch.com/mhra-flags-data-integrity-in-gcp-inspection-report/ 2017-08-10T20:15:29+00:00 https://biolegacyresearch.com/fda-ema-collaborate-on-model-for-developing-rare-pediatric-drugs/ 2017-08-10T20:22:36+00:00 https://biolegacyresearch.com/white-house-to-declare-national-emergency-over-opioid-abuse/ 2017-08-10T21:39:14+00:00 https://biolegacyresearch.com/united-therapeutics-sues-fda-for-denying-exclusive-marketing-rights-for-orphan-drug/ 2017-08-10T21:40:03+00:00 https://biolegacyresearch.com/experts-say-proposal-for-value-based-pricing-of-antimicrobials-has-potential/ 2017-08-10T21:40:53+00:00 https://biolegacyresearch.com/bleeding-money-s-nanthealth-restructures-and-lays-off-300/ 2017-08-11T00:00:00+00:00 https://biolegacyresearch.com/neovasc-announces-results-for-the-second-quarter-of-2017/ 2017-08-11T00:00:00+00:00 https://biolegacyresearch.com/former-pfizer-scientist-led-startup-zai-lab-taps-banks-for-150m-ipo/ 2017-08-11T00:00:00+00:00 https://biolegacyresearch.com/bostons-neosync-nabs-13-million-in-financing/ 2017-08-11T00:00:00+00:00 https://biolegacyresearch.com/glaxosmithkline-ditches-ionis-pharmas-inotersen-and-ionis-fb-lrx/ 2017-08-11T00:00:00+00:00 https://biolegacyresearch.com/leap-therapeutics-reports-second-quarter-2017-financial-results/ 2017-08-11T00:00:00+00:00 https://biolegacyresearch.com/perrigo-unveils-sale-of-two-business-units/ 2017-08-11T00:00:00+00:00 https://biolegacyresearch.com/recro-pharma-reports-inducement-grants-for-new-staff/ 2017-08-11T00:00:00+00:00 https://biolegacyresearch.com/peregrine-slashes-workforce-by-20-in-cost-cutting-plan/ 2017-08-11T00:00:00+00:00 https://biolegacyresearch.com/enteromedics-announces-proposed-underwritten-public-offering/ 2017-08-11T00:00:00+00:00 https://biolegacyresearch.com/ppds-recognized-for-industry-leadership/ 2017-08-11T00:00:00+00:00 https://biolegacyresearch.com/dova-pharma-reports-second-quarter-2017-operating-and-financial-results/ 2017-08-11T00:00:00+00:00 https://biolegacyresearch.com/syndax-reports-second-quarter-2017-financial-results-and-provides-clinical-and-business-update/ 2017-08-11T00:00:00+00:00 https://biolegacyresearch.com/cardiovascular-systems-touts-1-year-sub-analysis-data-from-liberty-pvi-study/ 2017-08-11T00:00:00+00:00 https://biolegacyresearch.com/right-to-try-laws-could-dampen-industry-participation-in-expanded-access-programs/ 2017-08-11T21:46:15+00:00 https://biolegacyresearch.com/lawsuit-claims-cvs-overcharged-insured-customers-for-drugs/ 2017-08-11T21:47:04+00:00 https://biolegacyresearch.com/appeals-court-dismisses-amgens-epogen-biosimilar-appeal/ 2017-08-11T21:47:48+00:00 https://biolegacyresearch.com/hi-tech-pharmacal-short-on-sterility-fda-says/ 2017-08-11T21:48:35+00:00 https://biolegacyresearch.com/merck-co-ceo-resigns-from-american-manufacturing-council-by-tweet/ 2017-08-14T00:00:00+00:00 https://biolegacyresearch.com/worldwide-clinical-trials-experts-to-advance-discussion-on-innovative-strategies-for-translational-research-services/ 2017-08-14T00:00:00+00:00 https://biolegacyresearch.com/bvicarius-pharmab-launches-with-21-8-million-and-will-be-helmed-by-former-biogen-elan-exec/ 2017-08-14T00:00:00+00:00 https://biolegacyresearch.com/repros-therapeutics-reports-second-quarter-2017-financial-results/ 2017-08-14T00:00:00+00:00 https://biolegacyresearch.com/fda-puts-in-place-new-hiring-protocols-for-foreign-scientists/ 2017-08-14T00:00:00+00:00 https://biolegacyresearch.com/dubai-health-authority-implements-masimo-patient-safetynet/ 2017-08-14T00:00:00+00:00 https://biolegacyresearch.com/ophthotechs-wet-amd-drug-fails-to-meet-primary-endpoint-in-phase-iii-study/ 2017-08-14T00:00:00+00:00 https://biolegacyresearch.com/gtx-corp-provides-corporate-update-and-reports-second-quarter-2017-financial-results/ 2017-08-14T00:00:00+00:00 https://biolegacyresearch.com/tiny-virtual-biotech-cellact-forges-250-million-chemo-rd-pact-with-mundipharma/ 2017-08-14T00:00:00+00:00 https://biolegacyresearch.com/synthorx-appoints-as-senior-vice-president-of-research/ 2017-08-14T00:00:00+00:00 https://biolegacyresearch.com/full-issue-drug-industry-daily/ 2017-08-14T22:09:45+00:00 https://biolegacyresearch.com/chinas-high-court-pushes-for-severe-penalties-for-falsifying-clinical-trial-documents/ 2017-08-14T22:10:39+00:00 https://biolegacyresearch.com/ema-calls-for-details-narratives-in-marketing-applications/ 2017-08-14T22:11:37+00:00 https://biolegacyresearch.com/mylan-receives-doj-subpoena-over-opioid-marketing/ 2017-08-14T22:12:29+00:00 https://biolegacyresearch.com/german-inspectors-fault-dr-reddys-facility-in-india-call-for-eu-import-ban/ 2017-08-14T22:13:12+00:00 https://biolegacyresearch.com/cohbar-announces-second-quarter-2017-financial-results/ 2017-08-15T00:00:00+00:00 https://biolegacyresearch.com/what-you-need-to-know-about-merck-co-s-fearless-ceo/ 2017-08-15T00:00:00+00:00 https://biolegacyresearch.com/spherix-announces-the-addition-of-to-companys-technology-advisory-board/ 2017-08-15T00:00:00+00:00 https://biolegacyresearch.com/biotech-startup-gets-grant-to-triple-its-workforce/ 2017-08-15T00:00:00+00:00 https://biolegacyresearch.com/prometic-life-sci-reports-2017-second-quarter-highlights-and-financial-results/ 2017-08-15T00:00:00+00:00 https://biolegacyresearch.com/sihuan-pharma-opens-up-rd-shop-in-the-san-francisco-bay-area/ 2017-08-15T00:00:00+00:00 https://biolegacyresearch.com/staar-surgical-and-announce-strategic-cooperation-agreement/ 2017-08-15T00:00:00+00:00 https://biolegacyresearch.com/struggling-teva-loses-top-rd-exec-to-eli-lilly-novartis-ag-backed-cavion/ 2017-08-15T00:00:00+00:00 https://biolegacyresearch.com/genenews-announces-q2-2017-financial-results-provides-progress-update/ 2017-08-15T00:00:00+00:00 https://biolegacyresearch.com/as-its-ceo-retires-cerecor-divests-depression-drug-to-pharma-giant-in-45-million-deal/ 2017-08-15T00:00:00+00:00 https://biolegacyresearch.com/ema-updates-eudravigilance-qas-with-over-100-questions-from-sponsors/ 2017-08-15T22:28:27+00:00 https://biolegacyresearch.com/fda-asks-drugmakers-to-report-pdufa-eligible-products-orange-book-changes/ 2017-08-15T22:31:23+00:00 https://biolegacyresearch.com/two-compounding-pharmacies-lose-exemptions-draw-fda-flags/ 2017-08-15T22:31:45+00:00 https://biolegacyresearch.com/coherus-files-ptab-petition-against-amgens-enbrel/ 2017-08-15T22:33:22+00:00 https://biolegacyresearch.com/bristol-myers-squibbs-stock-topples-as-kidney-cancer-drug-flunks-phase-iii-study/ 2017-08-16T00:00:00+00:00 https://biolegacyresearch.com/interpace-diagnostics-announces-coverage-of-thyroid-test-by/ 2017-08-16T00:00:00+00:00 https://biolegacyresearch.com/gilead-to-unveil-new-socal-facility-that-could-house-up-to-500-employees/ 2017-08-16T00:00:00+00:00 https://biolegacyresearch.com/vanc-pharmaceuticals-appoints-to-board-of-directors/ 2017-08-16T00:00:00+00:00 https://biolegacyresearch.com/how-eli-lilly-allegedly-used-a-fake-rule-and-fake-news-to-protect-bad-patents/ 2017-08-16T00:00:00+00:00 https://biolegacyresearch.com/bjaguar-health-companyb-name-now-updated-on-nasdaq-com-post-merger/ 2017-08-16T00:00:00+00:00 https://biolegacyresearch.com/johnson-johnson-ceo-to-stay-on-council-to-go-to-bat-for-health-care/ 2017-08-16T00:00:00+00:00 https://biolegacyresearch.com/obseva-reports-second-quarter-2017-financial-results-and-provides-business-update/ 2017-08-16T00:00:00+00:00 https://biolegacyresearch.com/jounce-names-ex-ariads-top-dealmaker-as-its-new-cbo/ 2017-08-16T00:00:00+00:00 https://biolegacyresearch.com/glytec-nabs-fourth-fda-510k-clearance-for-its-market-leading-diabetes-therapy-management-software/ 2017-08-16T00:00:00+00:00 https://biolegacyresearch.com/par-claims-former-employees-stole-trade-secrets-before-joining-quva-pharma/ 2017-08-16T22:28:43+00:00 https://biolegacyresearch.com/maryland-defends-price-gouging-law-against-aam-suit/ 2017-08-16T22:29:44+00:00 https://biolegacyresearch.com/phrma-hits-fda-for-unnecessary-prescription-drug-advertising-research/ 2017-08-16T22:30:35+00:00 https://biolegacyresearch.com/drug-companies-illegally-lobbied-against-drug-price-ballot-initiative-ohio-group-alleges/ 2017-08-16T22:31:37+00:00 https://biolegacyresearch.com/south-carolina-sues-purdue-claims-deceptive-marketing-of-opioid/ 2017-08-16T22:33:03+00:00 https://biolegacyresearch.com/novartis-ag-lures-superstar-scientist-away-from-ucsf/ 2017-08-17T00:00:00+00:00 https://biolegacyresearch.com/bluerock-therapeutics-expands-toronto-presence-with-rd-and-manufacturing-hub-appoints-key-rd-leadership/ 2017-08-17T00:00:00+00:00 https://biolegacyresearch.com/this-is-what-happens-when-the-fda-approves-cancer-drugs-too-quickly/ 2017-08-17T00:00:00+00:00 https://biolegacyresearch.com/argenx-to-host-conference-call-webcast-to-report-second-quarter-business-update-and-half-year-2017-financial-results-on-august-24-2017/ 2017-08-17T00:00:00+00:00 https://biolegacyresearch.com/johnson-johnson-ceo-backpedals-and-quits-right-before-disbands-council/ 2017-08-17T00:00:00+00:00 https://biolegacyresearch.com/endologix-announces-positive-clinical-results-from-the-leopard-clinical-study/ 2017-08-17T00:00:00+00:00 https://biolegacyresearch.com/bayer-healthcare-expansion-brings-new-jobs-to-the-bay-area/ 2017-08-17T00:00:00+00:00 https://biolegacyresearch.com/analogics-connect-checkpoint-ct-scanner-to-make-its-debut-for-the-americas-at/ 2017-08-17T00:00:00+00:00 https://biolegacyresearch.com/arcus-biosciences-wuxi-biologics-hammer-out-rd-cancer-pact-worth-816-million/ 2017-08-17T00:00:00+00:00 https://biolegacyresearch.com/immunomedics-announces-fiscal-2017-results-and-strategic-developments-reiterates-guidance-on-bla-submission-timeline/ 2017-08-17T00:00:00+00:00 https://biolegacyresearch.com/lawmakers-ask-drug-firms-to-justify-ms-drug-price-hikes/ 2017-08-17T21:48:54+00:00 https://biolegacyresearch.com/biocon-to-re-submit-biosimilar-applications-to-ema/ 2017-08-17T21:49:55+00:00 https://biolegacyresearch.com/for-emergency-ok-of-expanded-drug-access-after-dark-call-us-fda-says/ 2017-08-17T21:50:43+00:00 https://biolegacyresearch.com/jazz-pharma-announces-offering-of-500-million-of-1-50-exchangeable-senior-notes-due-2024/ 2017-08-18T00:00:00+00:00 https://biolegacyresearch.com/meet-the-biopharma-vet-frantically-raising-cash-for-his-biotech-startup/ 2017-08-18T00:00:00+00:00 https://biolegacyresearch.com/quest-diagnostics-declares-quarterly-cash-dividend/ 2017-08-18T00:00:00+00:00 https://biolegacyresearch.com/the-3-absolute-best-biotech-stocks-right-now/ 2017-08-18T00:00:00+00:00 https://biolegacyresearch.com/bvictoria-laughmanb-named-executive-vice-president-of-sales-for-opko-healths-bioreference/ 2017-08-18T00:00:00+00:00 https://biolegacyresearch.com/fda-green-lights-pfizer-drug-for-rare-fast-killing-type-of-leukemia/ 2017-08-18T00:00:00+00:00 https://biolegacyresearch.com/brosalind-franklin-universityb-researcher-awarded-2-million-from-nih-to-study-role-of-hormone-oxytocin-in-stress-fear-and-anxiety/ 2017-08-18T00:00:00+00:00 https://biolegacyresearch.com/heads-up-tesaro-astrazeneca-plc-merck-co-s-ovarian-cancer-drug-just-got-expanded-use-from-the-fda/ 2017-08-18T00:00:00+00:00 https://biolegacyresearch.com/the-alliance-for-regenerative-medicine-arm-releases-q2-2017-data-report-highlighting-sector-trends-and-metrics/ 2017-08-18T00:00:00+00:00 https://biolegacyresearch.com/lifenet-to-create-hundred-of-new-jobs-in-virginia-through-hq-expansion/ 2017-08-18T00:00:00+00:00 https://biolegacyresearch.com/president-signs-fda-user-fee-renewal-bill/ 2017-08-19T18:43:29+00:00 https://biolegacyresearch.com/fda-offers-guidance-on-whos-who-under-drug-supply-chain-law/ 2017-08-19T18:44:47+00:00 https://biolegacyresearch.com/fda-seeks-comments-on-risk-information-in-prescription-drug-broadcast-ads/ 2017-08-19T18:45:00+00:00 https://biolegacyresearch.com/court-rules-taiwanese-company-infringed-on-supernus-oxtellar-patents/ 2017-08-19T18:48:54+00:00 https://biolegacyresearch.com/boston-scientific-to-participate-in-2017-healthcare-conference/ 2017-08-21T00:00:00+00:00 https://biolegacyresearch.com/how-roches-300-million-campus-transformation-targets-the-new-generation-of-biotech-workers/ 2017-08-21T00:00:00+00:00 https://biolegacyresearch.com/cutera-strengthens-leadership-team-with-two-key-executive-appointments/ 2017-08-21T00:00:00+00:00 https://biolegacyresearch.com/biosimilars-giant-takes-the-plunge-into-original-biotech-drugs-via-takeda-deal/ 2017-08-21T00:00:00+00:00 https://biolegacyresearch.com/biotech-startups-flock-to-the-suburbs-over-rising-rent-prices/ 2017-08-21T00:00:00+00:00 https://biolegacyresearch.com/champions-oncology-surges-after-inking-rd-deal-with-this-drug-giant/ 2017-08-21T00:00:00+00:00 https://biolegacyresearch.com/trovagenes-plk1-inhibitor-pcm-075-demonstrates-synergy-with-a-hdac-inhibitor-in-non-hodgkin-lymphoma-cell-lines/ 2017-08-21T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-plc-jumps-deeper-into-mrna-drugs-with-ethris-deal/ 2017-08-21T00:00:00+00:00 https://biolegacyresearch.com/fda-steps-up-review-of-opioids-in-childrens-cough-and-cold-medicine/ 2017-08-21T20:38:51+00:00 https://biolegacyresearch.com/fdas-expedited-programs-predict-better-drugs-but-companies-are-still-slow-to-confirm-benefits-researchers-say/ 2017-08-21T20:40:20+00:00 https://biolegacyresearch.com/insys-settles-with-illinois-for-4-5-million-for-deceptive-opioid-marketing/ 2017-08-21T20:41:40+00:00 https://biolegacyresearch.com/fda-grounds-foshan-flying-medical-products/ 2017-08-21T20:42:49+00:00 https://biolegacyresearch.com/these-3-biotechs-could-have-the-most-exciting-late-stage-cancer-candidates/ 2017-08-22T00:00:00+00:00 https://biolegacyresearch.com/bionik-laboratories-corp-issues-letter-to-shareholders/ 2017-08-22T00:00:00+00:00 https://biolegacyresearch.com/shire-cfo-quits-for-boston-based-microbiome-startup/ 2017-08-22T00:00:00+00:00 https://biolegacyresearch.com/protea-biosciences-expands-clinical-study-for-new-melanoma-test/ 2017-08-22T00:00:00+00:00 https://biolegacyresearch.com/new-jersey-startup-launches-with-clinical-assets-from-big-name-biotechs/ 2017-08-22T00:00:00+00:00 https://biolegacyresearch.com/windtree-therapeutics-reports-second-quarter-2017-financial-results/ 2017-08-22T00:00:00+00:00 https://biolegacyresearch.com/gene-therapy-firm-files-for-35-million-ipo/ 2017-08-22T00:00:00+00:00 https://biolegacyresearch.com/helix-and-illumina-accelerator-partner-up-to-help-genomics-startups/ 2017-08-22T00:00:00+00:00 https://biolegacyresearch.com/sareptas-exondys-51-saga-continues-as-more-details-about-fdas-criticism-uncovered/ 2017-08-22T00:00:00+00:00 https://biolegacyresearch.com/phosphagenics-limited-signs-development-agreement-for-tpmoxymorphone-patch-in-japan/ 2017-08-22T00:00:00+00:00 https://biolegacyresearch.com/gottlieb-appoints-sherman-for-no-2-job-at-fda/ 2017-08-22T21:27:00+00:00 https://biolegacyresearch.com/fda-warns-canadian-drugmaker-for-refusing-photography-during-inspection/ 2017-08-22T21:28:00+00:00 https://biolegacyresearch.com/fda-to-tweak-pre-submission-draft-guidance-for-gdufa-ii/ 2017-08-22T21:28:11+00:00 https://biolegacyresearch.com/ema-outlines-generic-drugmaker-decisions-for-setting-dissolution-specifications/ 2017-08-22T21:29:05+00:00 https://biolegacyresearch.com/bostons-paratek-heads-to-the-auction-block/ 2017-08-23T00:00:00+00:00 https://biolegacyresearch.com/argentum-and-eli-lilly-settle-patent-dispute-over-cialis/ 2017-08-23T00:00:00+00:00 https://biolegacyresearch.com/this-drug-could-be-the-most-crucial-in-regenerons-massive-pipeline/ 2017-08-23T00:00:00+00:00 https://biolegacyresearch.com/bfeldan-therapeuticsb-announces-issuance-of-first-patent-for-its-peptide-based-protein-delivery-technology-the-feldan-shuttle/ 2017-08-23T00:00:00+00:00 https://biolegacyresearch.com/5-startups-to-watch-out-for/ 2017-08-23T00:00:00+00:00 https://biolegacyresearch.com/diffusion-pharma-names-chief-business-officer/ 2017-08-23T00:00:00+00:00 https://biolegacyresearch.com/altimmune-expands-to-new-hq-with-plans-for-new-jobs/ 2017-08-23T00:00:00+00:00 https://biolegacyresearch.com/gn-hearing-announces-availability-of-rechargeable-solution-for-the-recently-launched-resound-linx-3d/ 2017-08-23T00:00:00+00:00 https://biolegacyresearch.com/this-pharma-giant-doesnt-want-its-drug-used-in-death-penalty-executions/ 2017-08-23T00:00:00+00:00 https://biolegacyresearch.com/mabvax-therapeutics-announces-the-closing-of-1-3-million-registered-direct-offering-and-is-engaging-an-advisory-bank-to-explore-strategic-alternatives/ 2017-08-23T00:00:00+00:00 https://biolegacyresearch.com/fda-ema-agree-to-expanded-sharing-of-inspection-information/ 2017-08-23T22:24:32+00:00 https://biolegacyresearch.com/u-s-bioservices-settles-novartis-kickback-case/ 2017-08-23T22:27:12+00:00 https://biolegacyresearch.com/petition-asks-fda-to-prioritize-generic-trientine-andas/ 2017-08-23T22:28:36+00:00 https://biolegacyresearch.com/fda-warns-skin-care-drugmaker-in-the-philippines/ 2017-08-23T22:29:00+00:00 https://biolegacyresearch.com/karolinska-development-ab-interim-report-january-june-2017-invitation-to-conference-call-and-webcast/ 2017-08-24T00:00:00+00:00 https://biolegacyresearch.com/ionis-pharma-urges-investors-to-reject-the-below-the-market-offer-by/ 2017-08-24T00:00:00+00:00 https://biolegacyresearch.com/sectra-signs-breast-imaging-pacs-contract-with/ 2017-08-24T00:00:00+00:00 https://biolegacyresearch.com/seattles-omeros-fires-back-but-still-wont-answer-basic-questions-about-key-drug/ 2017-08-24T00:00:00+00:00 https://biolegacyresearch.com/ultragenyx-announces-burosumab-data-presentations-at-annual-meeting/ 2017-08-24T00:00:00+00:00 https://biolegacyresearch.com/job-cuts-and-facility-reductions-loom-over-socals-immunocellular/ 2017-08-24T00:00:00+00:00 https://biolegacyresearch.com/late-breaking-biotronik-study-results-to-be-presented-at-congress-2017/ 2017-08-24T00:00:00+00:00 https://biolegacyresearch.com/how-roche-fine-tuned-an-old-drug-under-a-new-name-to-keep-making-profits/ 2017-08-24T00:00:00+00:00 https://biolegacyresearch.com/incysus-announces-formation-of-scientific-advisory-board/ 2017-08-24T00:00:00+00:00 https://biolegacyresearch.com/illumina-spins-out-forensic-genetics-business-into-new-company/ 2017-08-24T00:00:00+00:00 https://biolegacyresearch.com/democrats-want-michigan-to-join-state-efforts-to-control-drug-prices/ 2017-08-24T21:40:31+00:00 https://biolegacyresearch.com/appeals-court-revives-antitrust-suit-over-generic-lipitor-effexor-xr/ 2017-08-24T21:41:18+00:00 https://biolegacyresearch.com/fda-draws-up-blueprint-for-pre-approval-facility-reviews/ 2017-08-24T21:42:12+00:00 https://biolegacyresearch.com/blake-insomnia-therapeutics-announces-submitting-clinical-trial-application-for-phase-ii-clinical-testing/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/vanc-pharmaceuticals-receives-updated-health-canada-approval-for-hema-fer-with-new-indication-for-use-in-pregnancy/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/troubled-dimension-therapeutics-sold-in-all-stock-deal/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/kedrion-and-kamada-receive-fda-approval-of-kedrab-for-post-exposure-prophylaxis-against-rabies-infection/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/the-fda-calls-kyowa-hakko-kirins-lymphoma-drug-a-breakthrough/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/boehringer-ingelheim-initiates-phase-iia-study-of-compound-acquired-from-pharmaxis-in-debilitating-liver-disease-nash/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/adamas-wins-fda-ok-for-the-first-and-only-drug-for-parkinsons-dyskinesia-drug/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/massachusetts-startup-srnalytics-develops-potent-small-rna-biomarker-sequencing-data/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/the-european-commission-ec-finally-approves-merck-kgaas-once-failed-ms-drug-cladribine/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/imraldi-biogens-adalimumab-biosimilar-referencing-humira-is-approved-in-the-european-union/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/cytrx-announces-receipt-of-nasdaq-listing-determination/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/genetic-tech-exploring-strategic-alternatives/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/index-pharmaceuticals-ab-interim-report-january-june-2017/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/caredx-confirms-allosure-will-receive-medicare-coverage-effective-october-9th-2017/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/auris-med-announces-receipt-of-nasdaq-notice/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/former-schering-plough-ceo-says-this-is-the-worst-solution-to-the-drug-pricing-dilemma/ 2017-08-25T00:00:00+00:00 https://biolegacyresearch.com/shorter-lists-help-consumers-absorb-more-risk-information-from-drug-ads/ 2017-08-25T22:45:50+00:00 https://biolegacyresearch.com/adamas-wins-approval-of-drug-for-dyskinesia-in-parkinsons-patients/ 2017-08-25T22:46:42+00:00 https://biolegacyresearch.com/ema-increased-gcp-inspections-in-2016/ 2017-08-25T22:47:30+00:00 https://biolegacyresearch.com/labeling-claims-for-colostrum-products-make-them-unapproved-drugs/ 2017-08-25T22:48:35+00:00 https://biolegacyresearch.com/hemostemix-completes-private-placement-and-rights-offering/ 2017-08-28T00:00:00+00:00 https://biolegacyresearch.com/csl-behring-scoops-up-this-u-s-biotech-for-416-million/ 2017-08-28T00:00:00+00:00 https://biolegacyresearch.com/bebs-technologiesb-appoints-bkarl-schweitzerb-as-chief-executive-officer/ 2017-08-28T00:00:00+00:00 https://biolegacyresearch.com/biogen-shows-off-more-positive-alzheimers-trial-data/ 2017-08-28T00:00:00+00:00 https://biolegacyresearch.com/humanigen-appoints-chief-financial-officer/ 2017-08-28T00:00:00+00:00 https://biolegacyresearch.com/belon-musksb-biotech-quietly-nabs-27-million-to-stick-machines-into-peoples-brains/ 2017-08-28T00:00:00+00:00 https://biolegacyresearch.com/abbott-introduces-heartmate-3-left-ventricular-assist-system-the-latest-milestone-in-therapy-for-advanced-heart-failure-patients/ 2017-08-28T00:00:00+00:00 https://biolegacyresearch.com/a-first-novartis-ag-drug-may-prevent-heart-attacks-and-cut-lung-cancer-risk-too/ 2017-08-28T00:00:00+00:00 https://biolegacyresearch.com/bgenetic-technologiesb-announces-comprehensive-review-of-strategic-alternatives/ 2017-08-28T00:00:00+00:00 https://biolegacyresearch.com/big-name-investor-funds-unethical-offshore-herpes-vaccine-trial/ 2017-08-28T00:00:00+00:00 https://biolegacyresearch.com/fda-unveils-spike-in-gdufa-fees-effective-oct-1/ 2017-08-28T21:47:00+00:00 https://biolegacyresearch.com/fda-slams-stem-cell-bad-actors-announces-new-regulatory-framework/ 2017-08-28T21:49:30+00:00 https://biolegacyresearch.com/hhs-moves-to-set-up-pain-management-task-force/ 2017-08-28T21:50:50+00:00 https://biolegacyresearch.com/fda-marks-down-compounder-for-aseptic-shortfalls/ 2017-08-28T21:54:47+00:00 https://biolegacyresearch.com/tekni-plex-begins-production-at-new-china-manufacturing-facility/ 2017-08-29T00:00:00+00:00 https://biolegacyresearch.com/jazz-pharma-bets-175-million-on-this-massachusetts-biotechs-antibody-drug-program/ 2017-08-29T00:00:00+00:00 https://biolegacyresearch.com/luminex-and-collaborate-to-improve-patient-care/ 2017-08-29T00:00:00+00:00 https://biolegacyresearch.com/enumeral-biomedical-gets-evicted-as-it-winds-down-operations/ 2017-08-29T00:00:00+00:00 https://biolegacyresearch.com/tyme-to-present-prostate-cancer-data-from-its-ongoing-phase-ii-trial-for-sm-88-at/ 2017-08-29T00:00:00+00:00 https://biolegacyresearch.com/allergan-is-laying-off-109-employees-in-socal-effective-october-23/ 2017-08-29T00:00:00+00:00 https://biolegacyresearch.com/btodos-medicalb-appoints-dr-bmeir-silverb-as-vice-president-of-clinical-research-and-regulatory-affairs/ 2017-08-29T00:00:00+00:00 https://biolegacyresearch.com/astrazeneca-plc-forges-400-million-parkinsons-rd-deal-with-takeda/ 2017-08-29T00:00:00+00:00 https://biolegacyresearch.com/therachon-appoints-biotechnology-leader-as-chief-medical-officer/ 2017-08-29T00:00:00+00:00 https://biolegacyresearch.com/acorda-plunges-after-the-fda-rejects-marketing-app-for-parkinsons-disease-drug/ 2017-08-29T00:00:00+00:00 https://biolegacyresearch.com/fda-revises-generic-digoxin-guidance-following-concordia-petition/ 2017-08-29T20:58:58+00:00 https://biolegacyresearch.com/pa-judge-rules-against-provigil-pay-for-delay-class-action-suit/ 2017-08-29T20:59:50+00:00 https://biolegacyresearch.com/judge-denies-eli-lilly-new-trial-after-20-million-patent-infringement-verdict/ 2017-08-29T21:00:52+00:00 https://biolegacyresearch.com/indias-hetero-labs-violated-gmp-standards-fda-said/ 2017-08-29T21:01:49+00:00 https://biolegacyresearch.com/belligo-health-researchb-names-bdeirdre-bevardb-as-chief-operating-officer/ 2017-08-30T00:00:00+00:00 https://biolegacyresearch.com/why-gilead-could-take-out-juno-but-face-major-competition-from-this-biotech-giant/ 2017-08-30T00:00:00+00:00 https://biolegacyresearch.com/gn-hearing-launches-resound-enzo-3d-and-beltone-boost-max-bringing-its-new-hearing-care-experience-to-people-with-severe-to-profound-hearing-loss/ 2017-08-30T00:00:00+00:00 https://biolegacyresearch.com/fired-pfizer-scientist-slated-for-2-more-retractions-bringing-the-total-to-7/ 2017-08-30T00:00:00+00:00 https://biolegacyresearch.com/neos-therapeutics-to-participate-in-three-september-conferences/ 2017-08-30T00:00:00+00:00 https://biolegacyresearch.com/bbiopharm-executiveb-what-could-trumps-meltdown-mean-for-biotech/ 2017-08-30T00:00:00+00:00 https://biolegacyresearch.com/sab-biotherapeutics-integrates-operations-with-new-production-facility/ 2017-08-30T00:00:00+00:00 https://biolegacyresearch.com/cancer-startup-nabs-21-million-and-sets-up-shop-in-kendall-square/ 2017-08-30T00:00:00+00:00 https://biolegacyresearch.com/bscientist-comb-launches-next-generation-innovation-hub-for-cutting-edge-drug-research-tools-and-technologies/ 2017-08-30T00:00:00+00:00 https://biolegacyresearch.com/otonomy-suspends-development-of-lead-drug-after-phase-iii-flop-stock-plunges/ 2017-08-30T00:00:00+00:00 https://biolegacyresearch.com/novartis-wins-landmark-approval-with-first-personalized-car-t-cancer-therapy/ 2017-08-30T21:22:40+00:00 https://biolegacyresearch.com/appeals-court-sides-with-fda-on-approval-of-abilify-competitor/ 2017-08-30T21:23:40+00:00 https://biolegacyresearch.com/ema-to-review-product-combination-packages-on-case-by-case-basis/ 2017-08-30T21:24:36+00:00 https://biolegacyresearch.com/compounder-lost-exemption-from-rules-then-violated-them-fda-said/ 2017-08-30T21:25:34+00:00 https://biolegacyresearch.com/bone-therapeutics-announces-h1-results-for-2017/ 2017-08-31T00:00:00+00:00 https://biolegacyresearch.com/theres-lots-of-work-at-the-top-10-worlds-largest-pharmaceutical-companies/ 2017-08-31T00:00:00+00:00 https://biolegacyresearch.com/filings-reveal-founder-ceo-buy-adds-570k-to-retractable-tech-stake/ 2017-08-31T00:00:00+00:00 https://biolegacyresearch.com/troubling-times-for-shire-as-execs-jump-ship-and-employee-satisfaction-is-at-an-all-time-low/ 2017-08-31T00:00:00+00:00 https://biolegacyresearch.com/mirati-therapeutics-to-participate-in-immuno-oncology-panel-discussion-at-the-2017-conference/ 2017-08-31T00:00:00+00:00 https://biolegacyresearch.com/incyte-discloses-promising-new-data-in-combo-drug-trial-with-merck-co-s-keytruda/ 2017-08-31T00:00:00+00:00 https://biolegacyresearch.com/commonwealth-diagnostics-announces-u-s-launch-and-new-global-developments/ 2017-08-31T00:00:00+00:00 https://biolegacyresearch.com/why-this-tiny-biotech-is-giving-cash-to-amgen-researchers/ 2017-08-31T00:00:00+00:00 https://biolegacyresearch.com/summit-therapeutics-reports-financial-results-for-the-second-quarter-and-half-year-ended-31-july-2017-and-operational-progress/ 2017-08-31T00:00:00+00:00 https://biolegacyresearch.com/daiichi-sankyo-terminates-650-million-deal-with-this-u-s-pharma/ 2017-08-31T00:00:00+00:00 https://biolegacyresearch.com/investment-losses-spur-mutual-fund-to-sue-valeant-alleging-it-is-a-criminal-enterprise/ 2017-08-31T22:55:35+00:00 https://biolegacyresearch.com/ema-to-update-aging-ich-guidelines-on-trial-statistics-and-reproductive-toxicology/ 2017-08-31T22:56:59+00:00 https://biolegacyresearch.com/ftc-orders-baxter-to-divest-rights-to-two-drugs-as-part-of-claris-takeover/ 2017-08-31T22:58:01+00:00 https://biolegacyresearch.com/johnson-johnson-dissolves-700-million-rd-deal-with-macrogenics/ 2017-09-01T00:00:00+00:00 https://biolegacyresearch.com/can-fite-biopharma-reports-second-quarter-2017-financial-results-provides-clinical-update/ 2017-09-01T00:00:00+00:00 https://biolegacyresearch.com/why-bristol-myers-squibb-could-be-the-answer-to-pfizers-pipeline-woes/ 2017-09-01T00:00:00+00:00 https://biolegacyresearch.com/the-cooper-companies-announces-third-quarter-2017-results/ 2017-09-01T00:00:00+00:00 https://biolegacyresearch.com/effective-today-cancer-biotech-immage-shutters-operations/ 2017-09-01T00:00:00+00:00 https://biolegacyresearch.com/rexahn-pharmaceuticals-inc-announces-retirement-of-its-founder-from-the-board-of-directors/ 2017-09-01T00:00:00+00:00 https://biolegacyresearch.com/scandal-ridden-proove-biosciences-sells-assets-founder-and-ceo-exits-amid-allegations/ 2017-09-01T00:00:00+00:00 https://biolegacyresearch.com/first-patient-at-implanted-in-endostims-less-gerd-clinical-trial-for-gastroesophageal-reflux-disease-gerd/ 2017-09-01T00:00:00+00:00 https://biolegacyresearch.com/former-celator-cpa-connived-with-two-friends-father-on-insider-trading-scheme/ 2017-09-01T00:00:00+00:00 https://biolegacyresearch.com/brhodes-collegeb-unveils-new-34-million-cutting-edge-science-facility/ 2017-09-01T00:00:00+00:00 https://biolegacyresearch.com/binternational-society-for-the-study-of-celiac-diseaseb-release-leading-immunologists-gather-in-new-delhi-to-confront-celiac-disease/ 2017-09-01T00:00:00+00:00 https://biolegacyresearch.com/nanobiotix-half-year-results-for-the-six-months-ended-30-june-2017/ 2017-09-01T00:00:00+00:00 https://biolegacyresearch.com/struggling-acorda-adopts-plan-to-fend-off-takeover-attempts/ 2017-09-01T00:00:00+00:00 https://biolegacyresearch.com/fda-begins-process-to-require-electronic-rems-document-submissions/ 2017-09-01T21:37:05+00:00 https://biolegacyresearch.com/arizona-and-missouri-move-against-opioid-manufacturers/ 2017-09-01T21:37:49+00:00 https://biolegacyresearch.com/new-mapp-outlines-internal-anda-verification-checklist-for-fda-reviewers/ 2017-09-01T21:38:47+00:00 https://biolegacyresearch.com/court-rules-mylan-chemical-companies-must-pay-insurers-67-million/ 2017-09-01T21:39:33+00:00 https://biolegacyresearch.com/aids-groups-call-on-new-york-ag-to-investigate-pay-for-delay-by-gilead/ 2017-09-01T21:40:40+00:00 https://biolegacyresearch.com/american-diabetes-association-and-collaborate-to-prevent-and-delay-type-2-diabetes/ 2017-09-05T00:00:00+00:00 https://biolegacyresearch.com/patient-dies-in-cellectis-groundbreaking-car-t-trial-forcing-a-halt-to-trials/ 2017-09-05T00:00:00+00:00 https://biolegacyresearch.com/psivida-to-report-fourth-quarter-and-fiscal-year-2017-financial-results-on-monday-september-11th/ 2017-09-05T00:00:00+00:00 https://biolegacyresearch.com/many-employees-moved-to-boston-as-part-of-takedas-transformation/ 2017-09-05T00:00:00+00:00 https://biolegacyresearch.com/report-on-transactions-with-alk-abello-as-b-shares-and-associated-securities-by-managerial-staff/ 2017-09-05T00:00:00+00:00 https://biolegacyresearch.com/socals-cytori-pink-slips-50-of-workforce-in-restructuring/ 2017-09-05T00:00:00+00:00 https://biolegacyresearch.com/clintec-international-expands-uk-headquarters-and-is-presented-with-queens-award-for-enterprise-international-trade/ 2017-09-05T00:00:00+00:00 https://biolegacyresearch.com/insmed-rockets-as-lung-drug-wows-in-late-stage-study/ 2017-09-05T00:00:00+00:00 https://biolegacyresearch.com/anavex-issued-new-u-s-patent-for-composition-of-matter-covering-anavex-2-73/ 2017-09-05T00:00:00+00:00 https://biolegacyresearch.com/takeda-jumps-into-the-land-of-car-t-rd-with-new-tie-up/ 2017-09-05T00:00:00+00:00 https://biolegacyresearch.com/phrma-bio-sue-to-block-nevada-diabetes-drug-price-transparency-law/ 2017-09-05T21:52:18+00:00 https://biolegacyresearch.com/opioid-promos-left-out-risks-fda-says-in-warning-letter/ 2017-09-05T21:53:04+00:00 https://biolegacyresearch.com/ema-launches-new-form-for-submitting-required-postmarket-data/ 2017-09-05T21:53:49+00:00 https://biolegacyresearch.com/ema-updates-advice-on-pursuing-chmp-opinions-for-products-for-non-eu-countries/ 2017-09-05T21:54:36+00:00 https://biolegacyresearch.com/phenomenex-announces-direct-sales-and-support-in-switzerland/ 2017-09-06T00:00:00+00:00 https://biolegacyresearch.com/tiny-bicycle-therapeutics-wrangles-a-424-million-rd-pact-with-biogen-spinoff-bioverativ/ 2017-09-06T00:00:00+00:00 https://biolegacyresearch.com/inflexxion-inc-announces-release-of-paincas-3-0-featuring-new-versions-of-soapp-and-comm/ 2017-09-06T00:00:00+00:00 https://biolegacyresearch.com/7-pdufa-dates-to-mark-on-your-calendars-for-september/ 2017-09-06T00:00:00+00:00 https://biolegacyresearch.com/dr-reddys-laboratories-ltd-announces-the-launch-of-metaxalone-tablets-usp-in-the-u-s-market/ 2017-09-06T00:00:00+00:00 https://biolegacyresearch.com/verastem-soars-as-blood-cancer-drug-succeeds-in-phase-iii-study/ 2017-09-06T00:00:00+00:00 https://biolegacyresearch.com/ironwood-announces-leadership-change/ 2017-09-06T00:00:00+00:00 https://biolegacyresearch.com/how-gilead-and-kite-pharmas-flirtation-became-the-real-thing/ 2017-09-06T00:00:00+00:00 https://biolegacyresearch.com/cure-pharma-launches-new-academic-partnership-program-providing-the-companys-proprietary-curefilm-for-more-humane-and-effective-animal-research/ 2017-09-06T00:00:00+00:00 https://biolegacyresearch.com/meet-the-4-vc-backed-biotech-startups-that-just-landed-space-in-kendall-square/ 2017-09-06T00:00:00+00:00 https://biolegacyresearch.com/mccaskill-accuses-insys-of-fueling-epidemic-in-first-opioid-investigation-report/ 2017-09-06T22:17:52+00:00 https://biolegacyresearch.com/fda-final-guidance-includes-reporting-scenarios-for-cell-and-tissue-based-products/ 2017-09-06T22:19:03+00:00 https://biolegacyresearch.com/hhs-adding-inflation-based-rebates-to-medicare-part-b-could-top-1-8-billion-in-savings/ 2017-09-06T22:19:54+00:00 https://biolegacyresearch.com/novo-nordisk-to-pay-58-million-to-settle-doj-suits-over-rems-violations/ 2017-09-06T22:20:48+00:00 https://biolegacyresearch.com/invidior-plans-to-appeal-verdict-in-suboxone-patent-case/ 2017-09-06T22:21:44+00:00 https://biolegacyresearch.com/brevon-systemsb-working-with-to-build-next-generation-clinical-algorithms/ 2017-09-07T00:00:00+00:00 https://biolegacyresearch.com/patient-death-forces-alnylam-to-suspend-dosing-in-hemophilia-trial-stock-plunges/ 2017-09-07T00:00:00+00:00 https://biolegacyresearch.com/spr-therapeutics-promotes-to-svp-of-research-and-development/ 2017-09-07T00:00:00+00:00 https://biolegacyresearch.com/fda-orders-6-partial-or-full-clinical-holds-on-celgenes-blood-cancer-studies/ 2017-09-07T00:00:00+00:00 https://biolegacyresearch.com/cipher-pharma-comments-on-fda-warning-letter-for-conzip-tramadol/ 2017-09-07T00:00:00+00:00 https://biolegacyresearch.com/fda-slaps-partial-hold-on-3-of-bristol-myers-squibbs-opdivo-based-combo-trials/ 2017-09-07T00:00:00+00:00 https://biolegacyresearch.com/bgbsib-biopolicy-summit-2017-explores-newest-lab-automation-digital-tools-and-technologies-promising-improved-preclinical-research-reproducibility-october-16-in-san-francisco/ 2017-09-07T00:00:00+00:00 https://biolegacyresearch.com/after-a-billion-loss-to-alzheimers-at-medivation-takes-another-shot-at-axovant/ 2017-09-07T00:00:00+00:00 https://biolegacyresearch.com/biotech-pioneer-submits-regulation-a-filing-with-for-up-to-50-million-initial-public-offering/ 2017-09-07T00:00:00+00:00 https://biolegacyresearch.com/cambridges-wuxi-nextcode-completes-a-whopping-240-million-funding-round/ 2017-09-07T00:00:00+00:00 https://biolegacyresearch.com/ema-updates-eudravigilance-qas-with-sponsors-questions/ 2017-09-07T18:34:38+00:00 https://biolegacyresearch.com/fda-releases-draft-guidance-on-child-resistant-packaging/ 2017-09-07T18:35:29+00:00 https://biolegacyresearch.com/drug-compounder-shut-down-after-fda-flags-potential-contamination/ 2017-09-07T18:36:52+00:00 https://biolegacyresearch.com/form-483-roundup-fda-cracks-down-on-non-sterile-workplaces/ 2017-09-07T18:45:34+00:00 https://biolegacyresearch.com/sens-warren-capito-push-awareness-of-law-allowing-partial-filling-of-opioid-prescriptions/ 2017-09-07T22:46:32+00:00 https://biolegacyresearch.com/fda-taking-suggestions-for-regulations-to-be-eliminated-under-trump-policy/ 2017-09-07T22:47:05+00:00 https://biolegacyresearch.com/shortcomings-by-the-score-at-chinese-drug-manufacturer-fda-said/ 2017-09-07T22:48:42+00:00 https://biolegacyresearch.com/rumors-swirl-again-over-astrazeneca-plc-and-this-4-4-billion-san-diego-biotech/ 2017-09-08T00:00:00+00:00 https://biolegacyresearch.com/bbiotech-and-moneyb-awards-gala-dinner-2017/ 2017-09-08T00:00:00+00:00 https://biolegacyresearch.com/2-biotechs-that-could-be-the-next-ma-targets/ 2017-09-08T00:00:00+00:00 https://biolegacyresearch.com/eton-pharma-appoints-to-its-board-of-directors/ 2017-09-08T00:00:00+00:00 https://biolegacyresearch.com/fda-calls-regeneron-sanofi-carcinoma-drug-a-breakthrough/ 2017-09-08T00:00:00+00:00 https://biolegacyresearch.com/bcapsovisionb-enhances-capsocam-plus-capsule-endoscopy-system-with-capsocloud/ 2017-09-08T00:00:00+00:00 https://biolegacyresearch.com/exiting-novartis-ag-ceo-sets-his-sights-on-silicon-valley-and-its-biotech-startups/ 2017-09-08T00:00:00+00:00 https://biolegacyresearch.com/nicox-sa-first-half-2017-business-and-financial-update/ 2017-09-08T00:00:00+00:00 https://biolegacyresearch.com/fda-berates-pfizer-unit-for-epipen-misfires-during-life-threatening-emergencies/ 2017-09-08T00:00:00+00:00 https://biolegacyresearch.com/celgene-releasedata-presented-at-2017-further-evaluate-role-of-abraxane-for-patients-with-historically-challenging-cancers/ 2017-09-08T00:00:00+00:00 https://biolegacyresearch.com/fda-advisory-committee-recommends-warning-for-gadolinium-mri-agents/ 2017-09-08T21:35:06+00:00 https://biolegacyresearch.com/ich-finalizes-qa-doc-on-justifying-drug-starting-materials/ 2017-09-08T21:36:30+00:00 https://biolegacyresearch.com/fda-researchers-seek-ways-to-avoid-shelf-life-chemical-reactions-in-complex-proteins/ 2017-09-08T21:37:45+00:00 https://biolegacyresearch.com/otsuka-loses-again-in-challenge-to-fda-green-light-for-competing-drug/ 2017-09-08T21:39:06+00:00 https://biolegacyresearch.com/acucela-granted-new-patent-covering-method-of-use-for-emixustat-hydrochloride/ 2017-09-11T00:00:00+00:00 https://biolegacyresearch.com/vida-diagnostics-enriches-pulmonary-suite-to-include-advanced-copd-and-asthma-analysis/ 2017-09-11T00:00:00+00:00 https://biolegacyresearch.com/zivo-bioscience-inc-kicks-off-final-phase-of-bovine-mastitis-study/ 2017-09-11T00:00:00+00:00 https://biolegacyresearch.com/johnson-johnson-quits-multibillion-dollar-hep-c-drug-program-partners-stocks-fall/ 2017-09-11T00:00:00+00:00 https://biolegacyresearch.com/bozmosib-launches-a-global-clinical-trials-database-to-transform-drug-development-forecasting/ 2017-09-11T00:00:00+00:00 https://biolegacyresearch.com/the-search-is-over-struggling-teva-finally-gets-a-new-ceo/ 2017-09-11T00:00:00+00:00 https://biolegacyresearch.com/immusant-inc-presents-data-from-multiple-studies-supporting-continued-development-of-nexvax2/ 2017-09-11T00:00:00+00:00 https://biolegacyresearch.com/why-this-bay-area-biotech-could-be-a-cash-cow-for-investors/ 2017-09-11T00:00:00+00:00 https://biolegacyresearch.com/iovance-biotherapeutics-partners-with-trakcel-for-personalized-patient-product-management/ 2017-09-11T00:00:00+00:00 https://biolegacyresearch.com/fda-asks-drugmakers-to-report-pdufa-products-orange-book-changes/ 2017-09-11T21:24:32+00:00 https://biolegacyresearch.com/teva-sued-by-hedge-funds-for-late-disclosure-of-doj-subpoena/ 2017-09-11T21:28:35+00:00 https://biolegacyresearch.com/anda-submissions-topped-1000-with-two-months-to-go-in-fy-2017/ 2017-09-11T21:29:45+00:00 https://biolegacyresearch.com/pto-grants-more-reviews-of-herceptin-patents-after-hospira-challenges/ 2017-09-11T21:31:53+00:00 https://biolegacyresearch.com/gottlieb-targets-more-efficient-clinical-trials/ 2017-09-11T22:08:59+00:00 https://biolegacyresearch.com/opioids-not-for-coughs-in-kids-fda-advisory-committee-says/ 2017-09-11T22:09:42+00:00 https://biolegacyresearch.com/pda-conference-baxter-cuts-483-rate-with-quality-matrix/ 2017-09-11T22:10:45+00:00 https://biolegacyresearch.com/galena-settles-kickback-allegations-for-7-5-million/ 2017-09-11T22:11:46+00:00 https://biolegacyresearch.com/natus-medical-pays-48-million-for-integra-lifesciences-neurosurgery-assets/ 2017-09-12T00:00:00+00:00 https://biolegacyresearch.com/riboxx-release-successful-industrial-gmp-manufacturing-of-riboxxim-a-novel-and-highly-potent-toll-like-3-ligand-for-immunotherapy-of-cancer/ 2017-09-12T00:00:00+00:00 https://biolegacyresearch.com/sage-therapeutics-crashes-hard-as-lead-epilepsy-drug-flunks-phase-iii-test/ 2017-09-12T00:00:00+00:00 https://biolegacyresearch.com/imris-reports-strong-financial-growth-following-two-year-anniversary-under-new-ownership/ 2017-09-12T00:00:00+00:00 https://biolegacyresearch.com/vertex-quietly-terminates-a-small-phase-ii-cf-trial/ 2017-09-12T00:00:00+00:00 https://biolegacyresearch.com/balzheimer-society-of-canadab-release-alzheimer-society-research-program-provides-3-4-million-boost-to-dementia-research/ 2017-09-12T00:00:00+00:00 https://biolegacyresearch.com/proqr-therapeutics-spins-out-cns-focused-biotech/ 2017-09-12T00:00:00+00:00 https://biolegacyresearch.com/reachbio-llc-celebrates-10-years-in-business/ 2017-09-12T00:00:00+00:00 https://biolegacyresearch.com/onxeo-plunges-after-liver-cancer-drug-fails-late-stage-study/ 2017-09-12T00:00:00+00:00 https://biolegacyresearch.com/veloxis-pharma-increases-share-capital-in-connection-with-exercise-of-warrants/ 2017-09-12T00:00:00+00:00 https://biolegacyresearch.com/fdas-has-big-plans-to-get-drugs-approved-faster-tackle-drug-development-costs/ 2017-09-12T00:00:00+00:00 https://biolegacyresearch.com/cybersecurity-bill-draws-support-from-healthcare-security-specialists/ 2017-09-12T20:58:44+00:00 https://biolegacyresearch.com/judge-rules-case-against-st-jude-defibrillators-can-go-ahead/ 2017-09-12T21:00:13+00:00 https://biolegacyresearch.com/german-sunlamp-company-burned-in-fda-warning-letter/ 2017-09-12T21:01:27+00:00 https://biolegacyresearch.com/chinese-medical-equipment-barred-from-import-by-fda/ 2017-09-12T21:02:27+00:00 https://biolegacyresearch.com/fda-adds-cybersecurity-standard-to-recognized-device-standards/ 2017-09-12T21:03:25+00:00 https://biolegacyresearch.com/five-deaths-from-obesity-treatment-balloons-prompt-new-labels/ 2017-09-12T21:09:19+00:00 https://biolegacyresearch.com/483-roundup-fda-flags-six-device-firms-for-gmp-other-deficiencies/ 2017-09-12T21:11:53+00:00 https://biolegacyresearch.com/australia-reports-more-infections-from-heater-cooler-devices/ 2017-09-12T21:13:00+00:00 https://biolegacyresearch.com/good-news-bad-news-for-bd-ok-on-lead-tests-but-other-problems/ 2017-09-12T21:14:02+00:00 https://biolegacyresearch.com/dhs-flags-hacking-risk-in-philips-radiation-monitoring-app/ 2017-09-12T21:15:17+00:00 https://biolegacyresearch.com/court-invalidates-five-mallinckrodt-patents/ 2017-09-12T22:10:56+00:00 https://biolegacyresearch.com/application-fees-going-up-for-rx-drugs-down-for-biosimilars-in-2018/ 2017-09-13T21:34:00+00:00 https://biolegacyresearch.com/congress-considers-new-fda-user-fees-for-over-the-counter-products/ 2017-09-13T21:34:55+00:00 https://biolegacyresearch.com/heart-drug-approvals-on-the-wane-study-says/ 2017-09-13T21:35:48+00:00 https://biolegacyresearch.com/homeopathic-drugmaker-violated-production-standards-fda-says/ 2017-09-13T21:36:45+00:00 https://biolegacyresearch.com/fda-approves-first-cancer-biosimilar-amgens-mvasi/ 2017-09-14T23:17:59+00:00 https://biolegacyresearch.com/fda-updates-2003-mapp-on-requesting-exemptions-from-environmental-assessment-requirements/ 2017-09-14T23:18:58+00:00 https://biolegacyresearch.com/industry-attorneys-ask-fda-to-narrow-off-label-communications-guidance/ 2017-09-14T23:19:00+00:00 https://biolegacyresearch.com/amgen-allergan-make-history-with-first-cancer-biosimilar-okmdashwill-take-on-genentechs-6-billion-best-seller/ 2017-09-15T00:00:00+00:00 https://biolegacyresearch.com/catabasis-to-present-results-from-the-open-label-extension-of-the-movedmd-phase-ii-trial-of-edasalonexent-in-duchenne-muscular-dystrophy-in-a-late-breaking-session-of-the-world-muscle-society/ 2017-09-15T00:00:00+00:00 https://biolegacyresearch.com/massachusetts-flexion-terminates-rd-deal-with-astrazeneca-plc/ 2017-09-15T00:00:00+00:00 https://biolegacyresearch.com/sales-of-olainfarm-in-august-increase-by-19/ 2017-09-15T00:00:00+00:00 https://biolegacyresearch.com/show-me-the-money-bay-areas-top-5-venture-capital-backed-biotechs/ 2017-09-15T00:00:00+00:00 https://biolegacyresearch.com/bzeissb-unveils-ultra-widefield-fundus-imaging-technology-in-u-s/ 2017-09-15T00:00:00+00:00 https://biolegacyresearch.com/novartis-ag-unloads-former-new-york-space-for-18-million-resold-for-30-million/ 2017-09-15T00:00:00+00:00 https://biolegacyresearch.com/medtronic-announces-inaugural-2017-global-champions-team/ 2017-09-15T00:00:00+00:00 https://biolegacyresearch.com/bavarian-nordic-plummets-49-after-cancer-vaccine-flunks-late-stage-test/ 2017-09-15T00:00:00+00:00 https://biolegacyresearch.com/bvalbiotisb-pascal-sirvent-appointed-director-of-discovery-and-preclinical-research/ 2017-09-15T00:00:00+00:00 https://biolegacyresearch.com/owc-pharmaceutical-research-corp-issues-chairmans-letter-to-shareholders/ 2017-09-15T00:00:00+00:00 https://biolegacyresearch.com/ipsen-announces-oral-and-poster-presentations-of-abobotulinumtoxina-data-at-the-2017-annual-meeting-of/ 2017-09-15T00:00:00+00:00 https://biolegacyresearch.com/efficacy-of-royal-philips-electronics-n-v-stellarex-035-low-dose-drug-coated-balloon-demonstrated-in-clinical-trial-at-two-years/ 2017-09-15T00:00:00+00:00 https://biolegacyresearch.com/bjaguar-healthb-subsidiary-napo-pharmaceuticals-inc-expands-mytesi-salesforce-with-hire-of-experienced-hiv-gi-drug-sales-reps-in-key-u-s-markets/ 2017-09-15T00:00:00+00:00 https://biolegacyresearch.com/court-upholds-38-million-judgment-against-abbott-over-epilepsy-drug/ 2017-09-15T22:28:17+00:00 https://biolegacyresearch.com/chmp-recommends-first-herceptin-biosimilar-12-other-medicines-for-eu-approval/ 2017-09-15T22:29:17+00:00 https://biolegacyresearch.com/doj-sides-with-sandoz-in-scotus-case-leftovers-against-amgen/ 2017-09-15T22:30:36+00:00 https://biolegacyresearch.com/ema-uk-firms-may-have-trouble-lifting-gmp-non-compliance-marks-post-brexit/ 2017-09-15T22:31:57+00:00 https://biolegacyresearch.com/fda-advisory-panel-splits-on-pediatric-labeling-for-opioid-patch/ 2017-09-15T22:33:18+00:00 https://biolegacyresearch.com/ignyta-reports-granting-of-inducement-awards/ 2017-09-18T00:00:00+00:00 https://biolegacyresearch.com/bkaleido-biosciencesb-emerges-from-stealth-mode-with-65-million-and-will-be-helmed-by-fomer-cubist-exec/ 2017-09-18T00:00:00+00:00 https://biolegacyresearch.com/achaogen-adds-as-chief-business-officer/ 2017-09-18T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-ultragenyx-swoops-in-with-138-million-bid-for-almost-sold-dimension-therapeutics/ 2017-09-18T00:00:00+00:00 https://biolegacyresearch.com/bjaguar-healthb-announces-proposed-public-offering-of-common-stock/ 2017-09-18T00:00:00+00:00 https://biolegacyresearch.com/teva-gains-another-2-48-billion-for-selling-the-last-of-its-womens-health-portfolio/ 2017-09-18T00:00:00+00:00 https://biolegacyresearch.com/medizone-to-host-investor-conference-call/ 2017-09-18T00:00:00+00:00 https://biolegacyresearch.com/nabrivas-stock-explodes-as-pneumonia-drug-wows-in-two-phase-iii-trials/ 2017-09-18T00:00:00+00:00 https://biolegacyresearch.com/biocryst-announces-full-exercise-of-underwriters-option-to-purchase-additional-shares-and-completion-of-public-offering-of-common-stock/ 2017-09-18T00:00:00+00:00 https://biolegacyresearch.com/harvard-biotech-guru-vcs-launch-with-55-million-series-a/ 2017-09-18T00:00:00+00:00 https://biolegacyresearch.com/hhs-says-almost-all-drug-wholesalers-meet-supply-chain-product-tracing-rules/ 2017-09-18T22:06:42+00:00 https://biolegacyresearch.com/let-drugmakers-create-their-own-rems-to-foster-generics-says-cvs/ 2017-09-18T22:07:39+00:00 https://biolegacyresearch.com/fdas-anda-approval-rate-slows-as-fiscal-year-nears-end/ 2017-09-18T22:08:30+00:00 https://biolegacyresearch.com/court-sides-with-ftc-in-pay-for-delay-suit-says-abbvie-patent-suits-were-baseless/ 2017-09-18T22:10:05+00:00 https://biolegacyresearch.com/court-sets-preliminary-15-million-settlement-in-allergan-subsidiary-antitrust-case/ 2017-09-18T22:10:55+00:00 https://biolegacyresearch.com/veracyte-launches-campaign-to-save-lives-through-early-screening-for-lung-cancer/ 2017-09-19T00:00:00+00:00 https://biolegacyresearch.com/growing-catalent-takes-out-cook-pharmica-in-950-million-deal/ 2017-09-19T00:00:00+00:00 https://biolegacyresearch.com/amerisourcebergen-and-commit-more-than-100000-to-support-victims-of-hurricanes-harvey-and-irma/ 2017-09-19T00:00:00+00:00 https://biolegacyresearch.com/how-gileads-12-billion-kite-pharma-deal-has-already-paid-off-for-investors/ 2017-09-19T00:00:00+00:00 https://biolegacyresearch.com/innovus-pharma-announces-the-launch-of-zestra-in-france-belgium-and-monaco-by-its-partner/ 2017-09-19T00:00:00+00:00 https://biolegacyresearch.com/booming-rho-to-go-on-40-person-hiring-binge/ 2017-09-19T00:00:00+00:00 https://biolegacyresearch.com/organogenesis-names-new-chief-commercial-officer-and-chief-operating-officer/ 2017-09-19T00:00:00+00:00 https://biolegacyresearch.com/former-glaxosmithkline-ceo-and-rd-boss-secure-new-gigs-at-biotech-vc-firms/ 2017-09-19T00:00:00+00:00 https://biolegacyresearch.com/agilent-joins-with-to-help-advance-scientific-discovery/ 2017-09-19T00:00:00+00:00 https://biolegacyresearch.com/biotech-startup-bonanza-continues-as-emerges-with-30-million/ 2017-09-19T00:00:00+00:00 https://biolegacyresearch.com/fda-guidance-will-advance-use-of-real-world-evidence-gottlieb-says/ 2017-09-19T21:53:46+00:00 https://biolegacyresearch.com/white-house-opioid-commission-announces-research-partnership/ 2017-09-19T21:55:00+00:00 https://biolegacyresearch.com/oncologic-drugs-committee-split-on-risk-benefit-profile-of-pfizer-candidate/ 2017-09-19T21:56:04+00:00 https://biolegacyresearch.com/fda-updates-interchangeable-pharmacopeia-guidelines-on-quality-testing-to-include-health-canada/ 2017-09-19T21:57:05+00:00 https://biolegacyresearch.com/fda-shoots-down-imports-from-south-korean-drugmaker/ 2017-09-19T21:57:49+00:00 https://biolegacyresearch.com/ema-takes-comments-on-radiopharmaceuticals-guidance/ 2017-09-19T22:40:41+00:00 https://biolegacyresearch.com/nice-links-cost-effectiveness-of-osteoporosis-drugs-with-fracture-risk/ 2017-09-19T22:41:55+00:00 https://biolegacyresearch.com/taiwanese-company-infringed-on-supernus-oxtellar-patents-court-says/ 2017-09-19T22:42:42+00:00 https://biolegacyresearch.com/bbenchlingb-announces-groundbreaking-workflow-results-management-solution-to-organize-optimize-and-measure-biologics-rd/ 2017-09-20T00:00:00+00:00 https://biolegacyresearch.com/alnylam-stock-catapults-as-genetic-disease-drug-meets-all-phase-iii-goals/ 2017-09-20T00:00:00+00:00 https://biolegacyresearch.com/bhearstb-invests-in-h-lee-moffitt-cancer-center-research-institute-subsidiary-m2gen/ 2017-09-20T00:00:00+00:00 https://biolegacyresearch.com/startup-whiz-kid-does-it-again-launches-bay-area-firm-to-revolutionize-clinical-trials/ 2017-09-20T00:00:00+00:00 https://biolegacyresearch.com/orphan-therapeutics-llc-applauds-for-trailblazer-lifetime-achievement-award/ 2017-09-20T00:00:00+00:00 https://biolegacyresearch.com/why-struggling-mannkind-is-struggling-no-more/ 2017-09-20T00:00:00+00:00 https://biolegacyresearch.com/xw-laboratories-inc-secures-over-17m-series-b-financing-led-by-and/ 2017-09-20T00:00:00+00:00 https://biolegacyresearch.com/tiny-massachusetts-biotech-corbus-to-triple-hq-space-to-accommodate-growth/ 2017-09-20T00:00:00+00:00 https://biolegacyresearch.com/aclaris-to-host-rd-and-investor-event-on-october-4-2017-in-new-york/ 2017-09-20T00:00:00+00:00 https://biolegacyresearch.com/pfizer-sues-jj-over-exclusionary-contracts-to-block-biosimilar-infliximab/ 2017-09-20T22:58:01+00:00 https://biolegacyresearch.com/ema-updates-18-year-old-guidelines-for-cardiovascular-clinical-trials/ 2017-09-20T22:59:02+00:00 https://biolegacyresearch.com/state-ags-expand-opioid-investigation-subpoena-distributors/ 2017-09-20T23:00:01+00:00 https://biolegacyresearch.com/lawsuit-review-finds-zero-liability-cases-involving-experimental-drugs-used-under-expanded-access/ 2017-09-20T23:00:59+00:00 https://biolegacyresearch.com/fda-moves-against-internet-drug-retailers/ 2017-09-20T23:01:52+00:00 https://biolegacyresearch.com/bay-areas-relievant-medsystems-names-a-new-ceo/ 2017-09-21T00:00:00+00:00 https://biolegacyresearch.com/baffinity-biob-partners-and-baffinity-bioceuticalsb/ 2017-09-21T00:00:00+00:00 https://biolegacyresearch.com/nestles-galderma-laboratories-to-slash-up-to-450-jobs-at-rd-center/ 2017-09-21T00:00:00+00:00 https://biolegacyresearch.com/brainlab-ag-snags-fda-win-for-two-new-indication-specific-radiosurgery-software-applications/ 2017-09-21T00:00:00+00:00 https://biolegacyresearch.com/once-prominent-bay-area-biotech-vc-faces-up-to-30-years-in-prison/ 2017-09-21T00:00:00+00:00 https://biolegacyresearch.com/oregon-bioscience-association-release-oregons-life-science-industry-on-display-oregon-bioscience-showcase-2017/ 2017-09-21T00:00:00+00:00 https://biolegacyresearch.com/sanofi-rd-boss-thinks-his-team-is-ready-to-survive-without-besties-regeneron-and-alnylam/ 2017-09-21T00:00:00+00:00 https://biolegacyresearch.com/bmanamedb-introduces-plasmaflow-the-worlds-first-fda-approved-digital-and-tubeless-deep-vein-thrombosis-prevention-device/ 2017-09-21T00:00:00+00:00 https://biolegacyresearch.com/new-kid-on-the-block-provention-bio-snags-2-clinic-ready-immune-compounds-from-johnson-johnson/ 2017-09-21T00:00:00+00:00 https://biolegacyresearch.com/poxel-reports-results-for-the-first-half-2017-and-provides-corporate-update/ 2017-09-21T00:00:00+00:00 https://biolegacyresearch.com/famed-genomics-pioneers-synthetic-genomics-hit-with-gender-discrimination-lawsuit-by-former-vp/ 2017-09-21T00:00:00+00:00 https://biolegacyresearch.com/woodcock-clinical-trial-system-is-broken-real-world-data-master-protocols-are-the-future/ 2017-09-21T23:04:36+00:00 https://biolegacyresearch.com/new-international-deal-lowers-price-of-generic-hiv-regimen-to-75-per-year/ 2017-09-21T23:05:25+00:00 https://biolegacyresearch.com/fda-draft-guidance-outlines-statistical-considerations-for-proving-biosimilarity/ 2017-09-21T23:06:24+00:00 https://biolegacyresearch.com/dxterity-collaborates-with-on-the-development-of-a-cancer-genomic-blood-test-to-predict-response-to-radiation-therapy/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-with-make-or-break-trial-results-fda-meetings-coming-soon/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/insys-hires-first-corporate-communications-leader-and-new-investor-relations-agency/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/bay-areas-impax-labs-surges-on-merger-buzz/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/cellular-biomedicine-group-plans-grand-opening-of-its-new-shanghai-facility/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/bay-area-versartiss-stock-collapses-as-growth-hormone-drug-flunks-phase-iii-test/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/bioasis-announces-voting-results-for-2017-annual-meeting/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/recent-cyberattack-on-merck-co-could-lead-to-drug-shortage/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/trinseo-announces-quarterly-dividend/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/bioprocess-international-conference-brings-biotech-together-in-boston/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/19-deaths-serious-liver-injury-linked-to-intercept-pharmas-ocaliva/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/calithera-biosciences-appoints-to-board-of-directors/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/milliporesigma-opens-chinas-first-bioreliance-end-to-end-biodevelopment-center-in-shanghai/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/gtx-corp-to-host-key-opinion-leader-luncheon-on-the-topic-of-stress-urinary-incontinence-on-september-28th-in-new-york-city/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/bavra-medical-roboticsb-updates-shareholders-and-the-investment-community-with-respect-to-recent-events-raising-bavrasb-visibility-in-the-medical-robotics-field/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/abivax-first-half-2017-financial-results-and-update/ 2017-09-22T00:00:00+00:00 https://biolegacyresearch.com/fda-wants-to-plug-in-sooner-to-drug-development-gottlieb-says/ 2017-09-22T22:16:29+00:00 https://biolegacyresearch.com/aegerion-admits-to-violating-rems-pushing-product-to-unapproved-populations/ 2017-09-22T22:17:18+00:00 https://biolegacyresearch.com/ema-delays-publication-of-clinical-study-reports/ 2017-09-22T22:18:09+00:00 https://biolegacyresearch.com/fda-goes-too-far-in-gdufa-ii-draft-guidance-aam-says/ 2017-09-22T22:19:01+00:00 https://biolegacyresearch.com/lawmakers-seek-merck-briefing-on-precautions-against-further-cyberattacks/ 2017-09-22T22:19:48+00:00 https://biolegacyresearch.com/public-citizen-sues-fda-over-failure-to-act-on-otc-petition/ 2017-09-22T22:20:44+00:00 https://biolegacyresearch.com/infinity-pharma-and-bristol-myers-squibb-expand-clinical-collaboration-evaluating-ipi-549-in-combination-with-opdivo-nivolumab/ 2017-09-25T00:00:00+00:00 https://biolegacyresearch.com/3-biotechs-on-their-way-to-monster-status/ 2017-09-25T00:00:00+00:00 https://biolegacyresearch.com/mallinckrodt-advocates-for-comprehensive-multi-prong-action-plan-to-fight-opioid-abuse-and-misuse-in-the-united-states/ 2017-09-25T00:00:00+00:00 https://biolegacyresearch.com/ex-akebia-director-re-arrested-after-insider-trading-prosecutors-call-him-unhinged/ 2017-09-25T00:00:00+00:00 https://biolegacyresearch.com/clinigen-and-cumberland-pharmaceuticals-launch-totect-in-the-u-s-for-emergency-oncology-intervention/ 2017-09-25T00:00:00+00:00 https://biolegacyresearch.com/fda-rejects-johnson-johnsons-ra-drug-sirukumab-more-safety-data-needed/ 2017-09-25T00:00:00+00:00 https://biolegacyresearch.com/spark-therapeutics-further-expands-gene-therapy-expertise-with-appointment-of-as-chief-scientific-officer/ 2017-09-25T00:00:00+00:00 https://biolegacyresearch.com/interim-ceo-named-permanent-leader-at-tango-therapeutics/ 2017-09-25T00:00:00+00:00 https://biolegacyresearch.com/22nd-century-group-inc-now-free-of-restrictive-license-agreement-with/ 2017-09-25T00:00:00+00:00 https://biolegacyresearch.com/tapimmune-brings-on-former-bellicum-exec-as-new-ceo/ 2017-09-25T00:00:00+00:00 https://biolegacyresearch.com/fda-ohrp-finalize-guidance-on-irb-meeting-minutes/ 2017-09-25T22:21:00+00:00 https://biolegacyresearch.com/fda-crackdown-on-illegal-online-pharmacies-part-of-broad-international-effort/ 2017-09-25T22:24:14+00:00 https://biolegacyresearch.com/fda-calls-for-further-studies-for-intellipharmaceutics-rexista/ 2017-09-25T22:26:04+00:00 https://biolegacyresearch.com/native-american-tribe-moves-to-dismiss-challenge-to-holding-of-allergan-patents/ 2017-09-25T22:26:57+00:00 https://biolegacyresearch.com/judge-sets-oct-17-for-next-industry-challenge-to-nevada-price-law/ 2017-09-25T22:27:46+00:00 https://biolegacyresearch.com/boehringer-ingelheim-partners-with-provides-over-half-a-million-dollars-in-product-aid-to-pets-affected-by-hurricanes-harvey-and-irma/ 2017-09-26T00:00:00+00:00 https://biolegacyresearch.com/axovants-much-hyped-alzheimers-drug-flunks-phase-iii-test/ 2017-09-26T00:00:00+00:00 https://biolegacyresearch.com/pliant-appoints-ph-d-as-vice-president-of-chemistry-and-m-d-ph-d-to-the-board-of-directors/ 2017-09-26T00:00:00+00:00